<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Aliment Pharmacol Ther</span><span class="iso-abbrev" title="iso-abbrev">Aliment. Pharmacol. Ther</span><span class="doi" title="doi">10.1111/(ISSN)1365-2036</span><span class="publisher-id" title="publisher-id">APT</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Alimentary Pharmacology &amp;amp; Therapeutics</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0269-2813</span><span class="issn-epub" tagx="issn" title="issn-epub">1365-2036</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">John Wiley and Sons Inc.</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Hoboken</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7267115">7267115</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1111/apt.15779">10.1111/apt.15779</a></span><span class="publisher-id" title="publisher-id">APT15779</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Review Article</span>: <span class="subject" title="subject">Review Articles</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Review article: prevention, diagnosis and management of COVIDâ€�19 in the IBD patient</div> <div class="alt-title" title="alt-title">
ALâ€�ANI et al.</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alâ€�Ani</span><span class="given-names" tagx="given-names" title="given-names">Aysha H.</span></span><a href="#apt15779-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prentice</span><span class="given-names" tagx="given-names" title="given-names">Ralley E.</span></span><a href="#apt15779-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rentsch</span><span class="given-names" tagx="given-names" title="given-names">Clarissa A.</span></span><a href="#apt15779-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Johnson</span><span class="given-names" tagx="given-names" title="given-names">Doug</span></span><a href="#apt15779-aff-0002"><sup>2</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ardalan</span><span class="given-names" tagx="given-names" title="given-names">Zaid</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-6952-0985</span><a href="#apt15779-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Heerasing</span><span class="given-names" tagx="given-names" title="given-names">Neel</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-0579-2062</span><a href="#apt15779-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garg</span><span class="given-names" tagx="given-names" title="given-names">Mayur</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-9149-3589</span><a href="#apt15779-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Campbell</span><span class="given-names" tagx="given-names" title="given-names">Sian</span></span><a href="#apt15779-aff-0002"><sup>2</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sasadeusz</span><span class="given-names" tagx="given-names" title="given-names">Joe</span></span><a href="#apt15779-aff-0002"><sup>2</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Macrae</span><span class="given-names" tagx="given-names" title="given-names">Finlay A.</span></span><a href="#apt15779-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ng</span><span class="given-names" tagx="given-names" title="given-names">Siew C.</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-6850-4454</span><a href="#apt15779-aff-0003"><sup>3</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rubin</span><span class="given-names" tagx="given-names" title="given-names">David T.</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-5647-1723</span><a href="#apt15779-aff-0004"><sup>4</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christensen</span><span class="given-names" tagx="given-names" title="given-names">Britt</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-8746-4275</span><a href="#apt15779-aff-0001"><sup>1</sup></a><span class="address" title="address"><span class="email" tagx="email" title="email">britt.christensen@mh.org.au</span></span></span></div><span class="citation_author_institution" id="apt15779-aff-0001">[1], <span class="named-content" title="named-content">Department of Gastroenterology</span><span class="institution" title="institution">The Royal Melbourne Hospital</span><span class="city" tagx="city" title="city">Melbourne</span><span class="named-content" title="named-content">Vic.</span><span class="country" tagx="country" title="country">Australia</span></span><span class="citation_author_institution" id="apt15779-aff-0002">[2], <span class="named-content" title="named-content">Victorian Infectious Diseases Unit</span><span class="institution" title="institution">The Royal Melbourne Hospital</span><span class="city" tagx="city" title="city">Melbourne</span><span class="named-content" title="named-content">Vic.</span><span class="country" tagx="country" title="country">Australia</span></span><span class="citation_author_institution" id="apt15779-aff-0003">[3], <span class="named-content" title="named-content">Department of Medicine and Therapeutics</span><span class="named-content" title="named-content">Institute of Digestive Disease</span><span class="named-content" title="named-content">State Key Laboratory of Digestive Diseases</span><span class="institution" title="institution">Li Ka Shing Institute of Health Science</span><span class="institution" title="institution">The Chinese University of Hong Kong</span><span class="city" tagx="city" title="city">Hong Kong Special Administrative Region</span><span class="country" tagx="country" title="country">China</span></span><span class="citation_author_institution" id="apt15779-aff-0004">[4], <span class="named-content" title="named-content">Inflammatory Bowel Disease Center</span><span class="institution" title="institution">University of Chicago Medicine</span><span class="city" tagx="city" title="city">Chicago</span><span class="named-content" title="named-content">IL</span><span class="country" tagx="country" title="country">USA</span></span><div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">*</span><b>Correspondence</b><br /><br /> Britt Christensen, The Royal Melbourne Hospital, Gastroenterology Department, 300 Grattan St, Parkville, Vic., Australia.<br /><br /> Email: <span class="email" tagx="email" title="email">britt.christensen@mh.org.au</span><br /><br /></div> </div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-5-5</span></span><span class="elocation-id" tagx="elocation-id" title="elocation-id">10.1111/apt.15779</span><span class="history" title="history"><span class="received" title="received">received: 2020-4-13</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-4-15</span><span class="accepted" title="accepted">accepted: 2020-4-17</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , </span><span class="license" title="license"><span class="license-p" title="license-p">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</span></span></div><a class="self-uri" href="file:APT-9999-na.pdf" title="self-uri">file:APT-9999-na.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Summary</div> <div class="background" title="sec"> <div class="title" tagx="title" title="title">
Background</div> <p>The current COVIDâ€�19 pandemic, caused by SARSâ€�CoVâ€�2, has emerged as a public health emergency. All nations are seriously challenged as the virus spreads rapidly across the globe with no regard for borders. The primary management of IBD involves treating uncontrolled inflammation with most patients requiring immuneâ€�based therapies. However, these therapies may weaken the immune system and potentially place IBD patients at increased risk of infections and infectious complications including those from COVIDâ€�19.</p> </div> <div class="aim" title="sec"> <div class="title" tagx="title" title="title">
Aim</div> <p>To summarise the scale of the COVIDâ€�19 pandemic, review unique concerns regarding IBD management and infection risk during the pandemic and assess COVIDâ€�19 management options and drug interactions in the IBD population.</p> </div> <div class="methods" title="sec"> <div class="title" tagx="title" title="title">
Methods</div> <p>A literature review on IBD, SARSâ€�CoVâ€�2 and COVIDâ€�19 was undertaken and relevant literature was summarised and critically examined.</p> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <p>IBD patients do not appear to be more susceptible to SARSâ€�CoVâ€�2 infection and there is no evidence of an association between IBD therapies and increased risk of COVIDâ€�19. IBD medication adherence should be encouraged to prevent disease flare but where possible highâ€�dose systemic corticosteroids should be avoided. Patients should exercise social distancing, optimise coâ€�morbidities and be up to date with influenza and pneumococcal vaccines. If a patient develops COVIDâ€�19, immune suppressing medications should be withheld until infection resolution and if trial medications for COVIDâ€�19 are being considered, potential drug interactions should be checked.</p> </div> <div class="conclusion" title="sec"> <div class="title" tagx="title" title="title">
Conclusion</div> <p>IBD patient management presents a challenge in the current COVIDâ€�19 pandemic. The primary focus should remain on keeping bowel inflammation controlled and encouraging medication adherence.</p> </div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> <div class="custom-meta-group" title="custom-meta-group"> <meta name="source-schema-version-number" value="2.0" /> <meta name="edited-state" value="corrected-proof" /> <meta name="details-of-publishers-convertor" value="Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.3 mode:remove_FC converted:03.06.2020" /> </div> </div> <p content-type="self-citation"><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Alâ€�Ani</span><span class="given-names" tagx="given-names" title="given-names">AH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Prentice</span><span class="given-names" tagx="given-names" title="given-names">RE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rentsch</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Review article: prevention, diagnosis and management of COVIDâ€�19 in the IBD patient</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">00</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">19</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1111/apt.15779">10.1111/apt.15779</a></span></span></p> <div class="fn-group" title="fn-group"> <div class="fn-type-" title=""> <p>The Handling Editor for this article was Professor Jonathan Rhodes, and this uncommissioned review was accepted for publication after full peerâ€�review.</p> </div> <div class="fn-type-" title=""> <p>AyshaÂ H. Alâ€�Ani and Ralley E. Prentice should be considered joint first authors.</p> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1</span><div class="title" tagx="title" title="title">
INTRODUCTION</div> <p>In December 2019, reports of a novel coronavirus, since named SARSâ€�CoVâ€�2, emerged from Wuhan, central Hubei Province, China.<a href="#apt15779-bib-0001"><sup>1</sup></a>, <a href="#apt15779-bib-0002"><sup>2</sup></a>, <a href="#apt15779-bib-0003"><sup>3</sup></a> The virus causes the disease COVIDâ€�19, which manifests as a severe acute respiratory illness that can be complicated by acute respiratory distress syndrome (ARDS), multiorgan failure and even death.<a href="#apt15779-bib-0003"><sup>3</sup></a> Following rapid spread of the virus across the globe, the World Health Organisation (WHO) declared COVIDâ€�19 a pandemic on 11 March 2020.<a href="#apt15779-bib-0002"><sup>2</sup></a> There are currently almost 2Â million confirmed cases across more than 200 countries with a total death count greater than 100Â 000 at the time of writing.<a href="#apt15779-bib-0002"><sup>2</sup></a> As the pandemic expands, there has been increasing concern regarding the impact of COVIDâ€�19 on patients with IBD.</p> <p>The primary management of IBD involves treating uncontrolled inflammation with a significant number of patients requiring immuneâ€�based therapies.<a href="#apt15779-bib-0004"><sup>4</sup></a> In the last decade, there has been a considerable expansion of the therapeutic armamentarium for patients with IBD to include immunomodulators, TNFÂ antagonists, nonâ€�TNFâ€�targeted biologics and targeted small molecule therapies.<a href="#apt15779-bib-0005"><sup>5</sup></a> However, these therapies, in addition to malnutrition which can complicate IBD, may weaken the immune system and potentially place IBD patients at increased risk of infections and infectious complications.<a href="#apt15779-bib-0006"><sup>6</sup></a></p> <p>Consequently, there is a concern that IBD patients are at greater risk of developing COVIDâ€�19 and at increased risk of progressing to a more severe clinical course or even death compared to the general population. In addition, if an IBD patient develops COVIDâ€�19, there is a lack of guidance on medication management and concern regarding drug interactions if trial medications are utilised to treat COVIDâ€�19.</p> <p>Therefore the aim of this review is to summarise the evidence and discuss in detail the data regarding the risks of developing COVIDâ€�19, strategies that can be implemented to reduce these risks and issues surrounding the treatment of COVIDâ€�19, including potential drug interactions and IBD medication management, in the IBD patient cohort.</p> </div> <div class="coronaviruses" title="sec"><span class="label" tagx="label" title="label">2</span><div class="title" tagx="title" title="title">
CORONAVIRUSES</div> <p>Coronaviruses (of the family coronaviridae) are a group of related singleâ€�stranded, positive sense, enveloped RNA viruses. They are the largest known RNA viruses, ranging from 26 to32 kilobases in size.<a href="#apt15779-bib-0007"><sup>7</sup></a> They are named after their appearance under electron microscopy, showing crown or halo (solar corona)â€�like spikes (virions) on their surface. <a href="#apt15779-bib-0008"><sup>8</sup></a> These viruses are capable of causing illness in humans and other mammals as well as birds.</p> <p>Human coronaviruses (HCoVs)Â were first discovered in 1960. There are currently seven known human coronaviruses: Human coronavirus 229EÂ (HCoVâ€�229E), Human coronavirus OC43Â (HCoVâ€�OC43), Human coronavirus HKU1Â (HCoVâ€�HKU1), Human coronavirus NL63Â (HCoVâ€�NL63), Severe Acute Respiratory Syndrome Coronavirus (SARSâ€�CoV), Middle Eastern Respiratory Syndrome Coronavirus (MERSâ€�CoV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARSâ€�CoVâ€�2). <a href="#apt15779-bib-0009"><sup>9</sup></a> These viruses are all known to cause respiratory symptoms ranging broadly in severity, both between the different viruses and in different hosts infected with the same virus. Most spread easily and result in relatively mild illness in immunocompetent patients, with certain strains being responsible for almost 30% of the common cold.<a href="#apt15779-bib-0010"><sup>10</sup></a></p> <p>Other coronaviruses (CoVs), including the SARSâ€�CoV and the MERSâ€�CoV, have previously emerged as epidemics with significant mortality and socioeconomic impact. Compared to SARSâ€�CoVâ€�2, MERSâ€�CoV causes a much more severe illness, with a caseâ€�fatality rateÂ (CFR) of up to 30%, but appears to have a lower personâ€�toâ€�person transmission, limiting its global impact.<a href="#apt15779-bib-0005"><sup>5</sup></a> There are still new cases of MERS being reported today.<a href="#apt15779-bib-0011"><sup>11</sup></a> Similarly, the SARSâ€�CoV outbreak in 2002â€�2003 had a high CFR (9.6%), but its reduced infectivity compared with SARSâ€�CoVâ€�2 lessened its overall impact.<a href="#apt15779-bib-0012"><sup>12</sup></a> This outbreak appears to have been contained.<a href="#apt15779-bib-0012"><sup>12</sup></a> SARSâ€�CoVâ€�2 is the first pandemic coronavirus. Therefore, it poses a threat of uncertain dimensions and represents uncharted territory for the public and global healthcare systems alike.<a href="#apt15779-bib-0002"><sup>2</sup></a>, <a href="#apt15779-bib-0003"><sup>3</sup></a></p> </div> <div class="sarsâ€�covâ€�2virusandcovidâ€�19" title="sec"><span class="label" tagx="label" title="label">3</span><div class="title" tagx="title" title="title">
SARSâ€�COVâ€�2 VIRUS AND COVIDâ€�19</div> <p>SARSâ€�CoVâ€�2, the virus previously known as novel 2019â€�coronavirus, causes the disease COVIDâ€�19. It was first discovered following the reports of an outbreak of pneumonia in China, with initial infections linked to a single seafood market.<a href="#apt15779-bib-0001"><sup>1</sup></a>, <a href="#apt15779-bib-0013"><sup>13</sup></a> Genetic studies have shown its genetic sequence is 82% similar to SARSâ€�CoV, and 89% similar to batâ€�SLâ€�CoVZC45 and batâ€�SLâ€�CoVZXC21, leading to the postulation that bats served as reservoir host for the new coronavirusâ€™ progenitor.<a href="#apt15779-bib-0014"><sup>14</sup></a> Human transmission is thought to have been facilitated by an animal intermediate host, currently hypothesised to be a pangolin.<a href="#apt15779-bib-0015"><sup>15</sup></a></p> <div class="transmission" title="sec"><span class="label" tagx="label" title="label">3.1</span><div class="title" tagx="title" title="title">
Transmission</div> <p>Humanâ€�toâ€�human transmission is believed to be predominantly via direct contact, exhaled droplets and fomites from an infected individual.<a href="#apt15779-bib-0016"><sup>16</sup></a> SARSâ€�CoVâ€�2 can also be detected in saliva, urine and the gastrointestinal tract in both biopsy specimens and stools, although their role in transmission remains unclear.<a href="#apt15779-bib-0017"><sup>17</sup></a>, <a href="#apt15779-bib-0018"><sup>18</sup></a>, <a href="#apt15779-bib-0019"><sup>19</sup></a> Data suggest it is more easily transmitted than seasonal influenza based on a basic reproduction number (R<sub>0</sub> â€� theÂ expected number of cases directly generated by one case in the population) of 2â€�2.5.<a href="#apt15779-bib-0020"><sup>20</sup></a></p> <p>Entry of coronaviruses into human target cells requires spike (S) protein binding to a cellular receptor followed by S protein priming by host proteases to facilitate cell entry.<a href="#apt15779-bib-0021"><sup>21</sup></a> SARSâ€�CoVâ€�2 humanâ€�toâ€�human transmission is enabled by the interaction of the SARSâ€�CoVâ€�2 Sâ€�protein with the human angiotensinâ€�converting enzyme 2 (ACE2) receptor.<a href="#apt15779-bib-0017"><sup>17</sup></a>, <a href="#apt15779-bib-0018"><sup>18</sup></a> Transmission occurs when the virus enters the nose, mouth or eyes, and potentially the digestive system and attaches to cells that produce ACE2. ACE2 are found in multiple organs and are highly expressed in lung AT2 cells, enterocytes of the small intestine and colon.<a href="#apt15779-bib-0022"><sup>22</sup></a>, <a href="#apt15779-bib-0023"><sup>23</sup></a> Once the virus is attached to ACE2 it uses the host serine protease TMPRSS2 for S priming allowing fusion of viral and cellular membranes and viral entry into the cell.<a href="#apt15779-bib-0021"><sup>21</sup></a></p> <p>Once a person develops initial symptoms of COVIDâ€�19, respiratory viral shedding occurs for a median of 20Â days in survivors and is sustained until death in nonsurvivors.<a href="#apt15779-bib-0024"><sup>24</sup></a> Of note, prolonged shedding has been demonstrated with other coronaviruses in immunocompromised patients<a href="#apt15779-bib-0025"><sup>25</sup></a> and in immunocompromised animals with MERSâ€�CoV.<a href="#apt15779-bib-0025"><sup>25</sup></a>, <a href="#apt15779-bib-0026"><sup>26</sup></a> However, the implications of this prolonged shedding are unknown as virus detected by PCR does not necessarily indicate viable virus or infectivity; a study of nine COVIDâ€�19 patients demonstrated that infectious virus was only isolated from samples taken before day 8 of symptom onset despite ongoing high viral loads and shedding after this time point.<a href="#apt15779-bib-0027"><sup>27</sup></a> Asymptomatic people are also potential sources of SARSâ€�CoVâ€�2 as transmission may occur in the preâ€�clinical period (2â€�14Â days) or from an oligosymptomatic individual.<a href="#apt15779-bib-0027"><sup>27</sup></a>, <a href="#apt15779-bib-0028"><sup>28</sup></a> Furthermore the virus has been detected in up to 50% of stool specimens and can remain positive for viral RNA following negative respiratory samples in more than 20% of SARSâ€�CoVâ€�2 patients.<a href="#apt15779-bib-0019"><sup>19</sup></a>, <a href="#apt15779-bib-0022"><sup>22</sup></a>, <a href="#apt15779-bib-0029"><sup>29</sup></a> These characteristics may have implications regarding isolation and decisionâ€�making for IBD patients who are infected with SARSâ€�CoVâ€�2 although there are no evidenceâ€�based guidelines on this currently.</p> </div> <div class="symptoms" title="sec"><span class="label" tagx="label" title="label">3.2</span><div class="title" tagx="title" title="title">
Symptoms</div> <p>The major clinical manifestations of COVIDâ€�19 are fever (44% on admission and 89% during admission), dry cough (68%), shortness of breath (19%), diarrhoea/vomiting/abdominal pain (20%), generalised myalgia/arthralgia (15%), headache (14%), malaise and bilateral interstitial pneumonia.<a href="#apt15779-bib-0015"><sup>15</sup></a>, <a href="#apt15779-bib-0019"><sup>19</sup></a>, <a href="#apt15779-bib-0030"><sup>30</sup></a> COVIDâ€�19 pneumonia manifests with chest CT imaging abnormalities, even in asymptomatic patients, with rapid evolution from focal unilateral to diffuse bilateral groundâ€�glass opacities that progress to or coâ€�exist with consolidations within 1â€�3Â weeks. <a href="#apt15779-bib-0015"><sup>15</sup></a></p> <p>While the mechanism of COVIDâ€�19 induced gastrointestinal symptoms remains to be clarified, enteric symptoms may occur due to malabsorption secondary to direct damage of the invaded enterocyte in the setting of a viral infection.<a href="#apt15779-bib-0018"><sup>18</sup></a> Furthermore, there is a recent case report of a possible SARSâ€�CoVâ€�2 gastrointestinal infection causing acute haemorrhagic colitis and signalling COVIDâ€�19 disease.<a href="#apt15779-bib-0031"><sup>31</sup></a> It is not clear if gastrointestinal symptom rates secondary to COVIDâ€�19 differ in patients with IBD but if an IBD patients presents with worsening gastrointestinal symptoms, COVIDâ€�19 infection should be considered as a differential.</p> </div> <div class="demographics" title="sec"><span class="label" tagx="label" title="label">3.3</span><div class="title" tagx="title" title="title">
Demographics</div> <p>The median age of an infected individual is 51Â years old and the majority of infected individuals range from 30 to 69Â years.<a href="#apt15779-bib-0016"><sup>16</sup></a> Fiftyâ€�one percent of reported cases is male. Healthcare workers may be at increased risk of infection secondary to close contact with infected patients and exposure to aerosolised virus from medical equipment and procedures including endoscopy.<a href="#apt15779-bib-0032"><sup>32</sup></a> In China healthcare workers made up 3.5% of COVIDâ€�19 patients and Italy have reported that 20% of its responding healthcare work force is being infected.<a href="#apt15779-bib-0017"><sup>17</sup></a>, <a href="#apt15779-bib-0033"><sup>33</sup></a> Current data suggest that children under the age of 18Â years have a low infection rate (2.4%), with a large proportion being identified through contact tracing in adults rather than through symptomatology.<a href="#apt15779-bib-0016"><sup>16</sup></a></p> </div> <div class="diseasecourse" title="sec"><span class="label" tagx="label" title="label">3.4</span><div class="title" tagx="title" title="title">
Disease course</div> <p>The median incubation period for SARSâ€�CoVâ€�2 is 4â€�5Â days, with most patients having symptom onset before 14Â days, but there have been cases with longer incubation.<a href="#apt15779-bib-0034"><sup>34</sup></a> A mean interval of 9.1â€�12.5Â days between illness onset and hospitalisation has been documented highlighting the challenge in the identification and isolation of individuals at an early stage of disease.<a href="#apt15779-bib-0035"><sup>35</sup></a> In recovered cases, the median time from initial symptoms to discharge from hospital was 22Â days and in those that succumbed the average time to death was 18.5Â days.<a href="#apt15779-bib-0035"><sup>35</sup></a></p> <p>Overall CFR of COVIDâ€�19 are estimated to be approximately 1%â€�2%, rising to more than 15% in patients aged 80Â years and over.<a href="#apt15779-bib-0036"><sup>36</sup></a> Current WHO data surmise that most cases of COVIDâ€�19 have mild to moderate disease (80%) with 13.8% experiencing severe disease defined by the following signs and symptoms within 24â€�48Â hours: shortness of breath; tachypnoea &amp;gt;30 breaths per minute; hypoxia &amp;lt;93%; hypoxaemia with PaO<sub>2</sub>/FiO<sub>2</sub> ratioÂ <div class="â_UNKNOWN">
50% of the lung field.<a href="#apt15779-bib-0016"><sup>16</sup></a> Critical infections occur in 6.1% and are exemplified by septic shock, respiratory failure and/or multiorgan failure.<a href="#apt15779-bib-0001"><sup>1</sup></a>, <a href="#apt15779-bib-0016"><sup>16</sup></a> Approximately one quarter of hospitalised patients require intensive care and 4.3% die.<a href="#apt15779-bib-0001"><sup>1</sup></a> The primary reason for transfer to ICU is the development of organ dysfunction with ARDS being the main catalyst.<a href="#apt15779-bib-0001"><sup>1</sup></a></div></p> </div> <div class="riskfactors" title="sec"><span class="label" tagx="label" title="label">3.5</span><div class="title" tagx="title" title="title">
Risk factors</div> <p>Risk factors for contracting COVIDâ€�19 have not been fully elucidated. Healthcare professionals are at greater risk secondary to increased exposure<a href="#apt15779-bib-0032"><sup>32</sup></a> and it is thought that smoking may exacerbate contraction.<a href="#apt15779-bib-0037"><sup>37</sup></a> For all patients with COVIDâ€�19, severity and mortality is associated with age (median age 66Â years for critically ill vs 51Â years in the overall patient population) and underlying cardiovascular disease, hypertension, chronic pulmonary disease, diabetes and cancer.<a href="#apt15779-bib-0016"><sup>16</sup></a>, <a href="#apt15779-bib-0017"><sup>17</sup></a>, <a href="#apt15779-bib-0038"><sup>38</sup></a> Severe COVIDâ€�19 is less common in children with reports suggesting approximately 5% develop severe disease and 0.6% become critical.<a href="#apt15779-bib-0039"><sup>39</sup></a> The crude fatality rate is higher in males (4.7%) vs females (2.8%) and smokers.<a href="#apt15779-bib-0016"><sup>16</sup></a>, <a href="#apt15779-bib-0017"><sup>17</sup></a>, <a href="#apt15779-bib-0035"><sup>35</sup></a> Risk factors are summarised in TableÂ <a href="#apt15779-tbl-0001">1</a>.</p> <div class="table-wrap_UNKNOWN" id="apt15779-tbl-0001" content-type="Table" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1</span> <p>hospital pharmacy for solution compounded from COVIDâ€�19 and developing severe complications</p>  <table frame="hsides" rules="groups"> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <tbody> <tr> <td align="left" rowspan="1" colspan="1">Possible risk factors for COVIDâ€�19 infection<a href="#apt15779-bib-0115"><sup>115</sup></a>, <a href="#apt15779-bib-0116"><sup>116</sup></a>, <a href="#apt15779-bib-0117"><sup>117</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Smoker</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Healthcare worker</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Nursingâ€�home/community living environment</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Possible risk factors for developing severe/critical COVIDâ€�19<a href="#apt15779-bib-0017"><sup>17</sup></a>, <a href="#apt15779-bib-0019"><sup>19</sup></a>, <a href="#apt15779-bib-0116"><sup>116</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">AgeÂ &amp;gt;Â 50</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diabetes</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hypertension</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Malignancy</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">COPD</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Smoker</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lymphopenia</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Neutropenia</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Higher LDH and Dâ€�dimer levels &amp;gt;1Â Âµg/mL on admission</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Postâ€�operative setting</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Corticosteroids</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">?Diarrhoea</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Further risk factors for death if admitted to ICU<a href="#apt15779-bib-0017"><sup>17</sup></a>, <a href="#apt15779-bib-0116"><sup>116</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tachycardia</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lymphopenia</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hypoxia</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Coagulopathy</td> </tr> </tbody> </table> <div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">John Wiley &amp;amp; Sons, Ltd</span>, </span><span class="license" title="license"><span class="license-p" title="license-p">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</span></span></div> </div> <p>Specific risk factors for developing COVIDâ€�19 in IBD patients are yet to be determined. For lower respiratory tract infections with seasonal (nonâ€�COVIDâ€�19) coronavirus, risk factors in other immunocompromised patient groups have included age &amp;gt;50Â years, receipt of corticosteroids, lymphopenia and neutropenia.<a href="#apt15779-bib-0026"><sup>26</sup></a>, <a href="#apt15779-bib-0040"><sup>40</sup></a> For IBD patients, the greatest risk factor for general immunosuppression and infections remains pharmacological.<a href="#apt15779-bib-0041"><sup>41</sup></a>, <a href="#apt15779-bib-0042"><sup>42</sup></a> Nutritional status, coâ€�morbidities, age and disease activity also contribute.<a href="#apt15779-bib-0042"><sup>42</sup></a>, <a href="#apt15779-bib-0043"><sup>43</sup></a> Of these, malnutrition (OR: 6.26 [95% CI: 1.20â€�32.78])<a href="#apt15779-bib-0041"><sup>41</sup></a>, <a href="#apt15779-bib-0042"><sup>42</sup></a> and disease activity (OR: 3.35 [95%CI: 1.23â€�9.23, <i>P</i>Â =Â 0.02])<a href="#apt15779-bib-0044"><sup>44</sup></a> are significant nonpharmacological risk factors that are modifiable for infection and therefore nutritional support and medical treatment aiming for disease control should be optimised.<a href="#apt15779-bib-0041"><sup>41</sup></a>, <a href="#apt15779-bib-0042"><sup>42</sup></a> Furthermore, low vitamin D levels are prevalent in IBD patients and may be associated with an increased risk and/or severity of influenza and COVIDâ€�19.<a href="#apt15779-bib-0045"><sup>45</sup></a>, <a href="#apt15779-bib-0046"><sup>46</sup></a> Vitamin D increases antiâ€�inflammatory cytokines and lowers viral replication, which in turn may reduce proâ€�inflammatory cytokines that propagate lung injury and ARDS.<a href="#apt15779-bib-0045"><sup>45</sup></a>, <a href="#apt15779-bib-0046"><sup>46</sup></a>, <a href="#apt15779-bib-0047"><sup>47</sup></a> Therefore assessment of vitamin D and supplementation when it is low is reasonable.</p> <p>As gastrointestinal tract permeability may be increased in IBD patients<a href="#apt15779-bib-0018"><sup>18</sup></a> with higher expression of ACE2 in inflamed bowel,<a href="#apt15779-bib-0048"><sup>48</sup></a> there is also a theoretical increased risk of SARSâ€�CoVâ€�2 infection via the gut in IBD patients. Despite this, there is no current evidence of increased infection rates or worse disease severity of COVIDâ€�19 in IBD patients. Indeed, so far, no patient with IBD has been reported to have contracted COVIDâ€�19 from the tertiary IBD centres in Wuhan where the virus originated<a href="#apt15779-bib-0049"><sup>49</sup></a> and, despite IBD being a reasonably common condition, very low rates have been described in an international COVIDâ€�IBD registry as of 11 April 2020. At time of writing, 457 (270 Crohn's disease [CD]; 185 UC/unspecified) cases of COVIDâ€�19 in IBD had been reported with 26% of CD and 36% of ulcerative colitis (UC) patients requiring hospitalisation and 3% of CD and 5% of UC patients requiring ICU. Fifteen deaths have been reported.<a href="#apt15779-bib-0050"><sup>50</sup></a> This appears to be a notable underâ€�representation of COVIDâ€�19 infection in IBD patients compared to the prevalence of IBD and COVIDâ€�19 separately in the community. As yet, it is unclear if this is secondary to low COVIDâ€�19 infection rates or to significant underâ€�reporting of COVIDâ€�19 infection in IBD patients.</p> </div> <div class="diagnosis" title="sec"><span class="label" tagx="label" title="label">3.6</span><div class="title" tagx="title" title="title">
Diagnosis</div> <p>A diagnosis of COVIDâ€�19 should be considered in patients who display fever, cough, anosmia, nausea, vomiting and diarrhoea. Of note, a subgroup of patients may present with mild disease marked by the presence of diarrhoea initially and these patients often experience delayed diagnosis compared to those that present with respiratory symptoms.<a href="#apt15779-bib-0051"><sup>51</sup></a> Biochemical markers of COVIDâ€�19 include lymphopenia, thrombocytopenia and leukopenia as well as elevated Câ€�reactive protein (CRP), which may also correlate with severe disease. <a href="#apt15779-bib-0017"><sup>17</sup></a> Less commonly, there may also be elevations in alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK) and Dâ€�dimer.<a href="#apt15779-bib-0017"><sup>17</sup></a></p> <p>Recommendations on whom to test for COVIDâ€�19 will vary depending on the local guidelines, availability of testing kits and regional transmission dynamics. In highâ€�risk settings where an outbreak has occurred, all patients with clinical features consistent with COVIDâ€�19 should be considered for testing. In nonâ€�outbreak areas, a case of COVIDâ€�19 should be suspected and tested for if a patient has clinical features suggestive of COVIDâ€�19 and fits epidemiologic criteria for example international travel or contact with a confirmed COVIDâ€�19 case. A patient is also considered a suspect case of COVIDâ€�19 regardless of their history if they are admitted to hospital with acute respiratory illness or unexplained fever.</p> <p>Diagnosis of COVIDâ€�19 is via nucleic acid testing of nasopharyngeal and oropharyngeal swabs.<a href="#apt15779-bib-0052"><sup>52</sup></a> Serology testing is currently not widely available. It is important to ensure that routine local protocols for testing in acute pneumonia/pneumonitis are also followed, such as bacterial cultures, urinary antigen testing, acute and convalescent serology and respiratory virus panels. At this stage, faecal sampling is not standard; however, this may be indicated in those with gastrointestinal symptoms. A positive test for COVIDâ€�19 must be immediately notified to the relevant communicable diseases agency.<a href="#apt15779-bib-0052"><sup>52</sup></a></p> </div> </div> <div class="managementofimmunosuppressionwithcovidâ€�19" title="sec"><span class="label" tagx="label" title="label">4</span><div class="title" tagx="title" title="title">
MANAGEMENT OF IMMUNOSUPPRESSION WITH COVIDâ€�19</div> <p>Despite a lack of evidence demonstrating any increased susceptibility to COVIDâ€�19,<a href="#apt15779-bib-0050"><sup>50</sup></a> medications used in the management of IBD have been shown to increase the risk of respiratory tract infections and serious infections to varying degrees (TableÂ <a href="#apt15779-tbl-0002">2</a>). However, theoretically, there may also be some beneficial effects seen with certain immunosuppressive medications, given the cause of death in COVIDâ€�19 isÂ a cytokine storm resulting in ARDS.</p> <div class="table-wrap_UNKNOWN" id="apt15779-tbl-0002" content-type="Table" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2</span> <p>IBD medications and infection risk</p>  <table frame="hsides" rules="groups"> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <thead valign="top"> <tr style="border-bottom:solid 1px #000000"> <th align="left" valign="top" rowspan="1" colspan="1">Â </th> <th align="left" valign="top" rowspan="1" colspan="1">Risk of respiratory tract infections</th> <th align="left" valign="top" rowspan="1" colspan="1">Risk of serious infections</th> </tr> </thead> <tbody> <tr> <td align="left" colspan="3" rowspan="1">Steroids</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Prednisolone</td> <td align="left" rowspan="1" colspan="1"> <p>URTI for influenza compared to placebo </p><ul> <li> <p>OR 1.22 (95% CI, 1.08â€�1.38)<a href="#apt15779-bib-0062"><sup>62</sup></a></p> </li> </ul> <p /> <p>LRTI compared to placebo </p><ul> <li> <p>OR 3.62 (95% CI 3.30â€�3.98)<a href="#apt15779-bib-0062"><sup>62</sup></a></p> </li> </ul> <p /> </td> <td align="left" rowspan="1" colspan="1">OR 1.92 (95% CI 0.36â€�10.21) compared to placebo<a href="#apt15779-bib-0063"><sup>63</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Budesonide</td> <td align="left" rowspan="1" colspan="1">No increase in adverse events compared with placebo<a href="#apt15779-bib-0118"><sup>118</sup></a></td> <td align="left" rowspan="1" colspan="1"> <p>RR 0.97 (95% CI 0.76â€�1.13) compared to placebo<a href="#apt15779-bib-0118"><sup>118</sup></a></p> <p>OR 0.73 (95% CI 0.36â€�1.50) Budesonide MMX compared to placebo<a href="#apt15779-bib-0069"><sup>69</sup></a></p> <p>OR 0.94 (95% CI 0.56â€�1.59) Budesonide compared to placebo<a href="#apt15779-bib-0069"><sup>69</sup></a></p> </td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Beclomethasone</td> <td align="left" rowspan="1" colspan="1">No increase in adverse events compared with placebo<a href="#apt15779-bib-0119"><sup>119</sup></a></td> <td align="left" rowspan="1" colspan="1"> <p>OR 0.30 (95% CI 0.01â€�8.29) compared to placebo<a href="#apt15779-bib-0069"><sup>69</sup></a></p> <p>OR 3.32 (95% CI 0.13â€�84.9) compared to prednisolone <a href="#apt15779-bib-0069"><sup>69</sup></a></p> </td> </tr> <tr> <td align="left" colspan="3" rowspan="1">Immunomodulators</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Thiopurines</td> <td align="left" rowspan="1" colspan="1">2.1 per patientâ€�years<a href="#apt15779-bib-0070"><sup>70</sup></a></td> <td align="left" rowspan="1" colspan="1">OR 0.143 (95% CI 0.43â€�4.76) compared to placebo<a href="#apt15779-bib-0070"><sup>70</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Methotrexate</td> <td align="left" rowspan="1" colspan="1">OR 1.02 (95% 0.88â€�1.19)<a href="#apt15779-bib-0073"><sup>73</sup></a> compared with placebo</td> <td align="left" rowspan="1" colspan="1">OR 0.52 (95% CI 0.04â€�6.34) compared to placebo<a href="#apt15779-bib-0073"><sup>73</sup></a></td> </tr> <tr> <td align="left" colspan="3" rowspan="1">Biologic therapy</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Antiâ€�TNF</td> <td align="left" rowspan="1" colspan="1"> <p>URTI </p><ul> <li> <p>Infliximab: 25% vs 9.8% placebo</p> </li> <li> <p>Adalimumab: 16.7% vs 14.5% placebo<a href="#apt15779-bib-0076"><sup>76</sup></a></p> </li> </ul> <p /> <p>LRTI compared to placebo </p><ul> <li> <p>OR 1.28 (95% CI: 1.08â€�1.52)<a href="#apt15779-bib-0062"><sup>62</sup></a></p> </li> </ul> <p /> </td> <td align="left" rowspan="1" colspan="1">OR 1.43 (95% CI: 1.11â€�1.84;Â <i>PÂ =</i>Â 0.006) compared to placebo<a href="#apt15779-bib-0075"><sup>75</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ustekinumab</td> <td align="left" rowspan="1" colspan="1"> <p>URTI </p><ul> <li> <p>10.7% in ustekinumab 12â€�weekly and 12.9% ustekinumab 8â€�weekly vs 7.5% placebo<a href="#apt15779-bib-0082"><sup>82</sup></a></p> </li> </ul> <p /> </td> <td align="left" rowspan="1" colspan="1">4.21 (95% CI 3.25â€�5.36) in ustekinumab group vs 3.97 (95% CI 2.05â€�6.97) in placebo per 100 patientâ€�years of followâ€�up<a href="#apt15779-bib-0082"><sup>82</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Vedolizumab</td> <td align="left" rowspan="1" colspan="1"> <p>URTI compared to placebo </p><ul> <li> <p>HR 1.23, logâ€�rankÂ <i>P =</i>Â .173<a href="#apt15779-bib-0120"><sup>120</sup></a></p> </li> </ul> <p /> <p>LRTI compared to placebo </p><ul> <li> <p>HR 0.95, logâ€�rankÂ <i>PÂ =</i>Â 0.851<a href="#apt15779-bib-0120"><sup>120</sup></a></p> </li> </ul> <p /> </td> <td align="left" rowspan="1" colspan="1">4.3/100 patientâ€�years (95% CI 3.7â€�4.9) vs 3.8/100 patientâ€�years (95% CI 1.2â€�6.4) for placebo <a href="#apt15779-bib-0086"><sup>86</sup></a></td> </tr> <tr> <td align="left" colspan="3" rowspan="1">Small molecule therapy</td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tofacitinib 5Â mg</td> <td align="left" rowspan="1" colspan="1"> <p>URTI </p><ul> <li> <p>4.5% sv 3.3% with placebo in RA patients<a href="#apt15779-bib-0121"><sup>121</sup></a></p> </li> </ul> <p /> <p>Nasopharyngitis 10% vs 2.8% placebo<a href="#apt15779-bib-0122"><sup>122</sup></a></p> </td> <td align="left" rowspan="1" colspan="1">2.3 (95% CI: 1.8 to 2.8) /100 patientâ€�years (in RA)<a href="#apt15779-bib-0123"><sup>123</sup></a></td> </tr> <tr> <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tofacitinib 10Â mg</td> <td align="left" rowspan="1" colspan="1"> <p>URTI </p><ul> <li> <p>6% vs 4% with placebo in UC patients<a href="#apt15779-bib-0122"><sup>122</sup></a></p> </li> </ul> <p /> <p>Nasopharyngitis 14% vs 2.8% placebo<a href="#apt15779-bib-0122"><sup>122</sup></a></p> </td> <td align="left" rowspan="1" colspan="1">2.7 (95% CI: 2.3 to 3.1)/100 patientâ€�years (in RA)<a href="#apt15779-bib-0123"><sup>123</sup></a></td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN" id="apt15779-ntgp-0002"> <div class="fn-type-" title=""> <p>Abbreviations: HR, hazard ratio; LRTI, lower respiratory tract infection; OR, odds ratio; RA, rheumatoid arthritis; CI, confidence interval; RR, relative risk; URTI, upper respiratory tract infection.</p> </div> </div> <div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">John Wiley &amp;amp; Sons, Ltd</span>, </span><span class="license" title="license"><span class="license-p" title="license-p">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</span></span></div> </div> <p>Overall, apart from corticosteroids, the risks of IBD therapies, particularly 5â€�ASAs and biologics, appear limited, and the importance of careful discussion regarding the risks versus benefits of medications with patients and among medical practitioners cannot be overstated. Inappropriate cessation of effective agents due to unjustified fear of adverse events may lead to IBD relapse, which when requiring the use of steroids or hospitalisation may inadvertently strain medical resources and increase the risk of COVIDâ€�19 exposure and infection.</p> <div class="sulfasalazineand5â€�aminosalicylates(5â€�asas)" title="sec"><span class="label" tagx="label" title="label">4.1</span><div class="title" tagx="title" title="title">
Sulfasalazine and 5â€�aminosalicylates (5â€�ASAs)</div> <p>Sulfasalazine and the 5â€�ASA medications are used as firstâ€�line induction and maintenance treatment for UC. 5â€�ASAs have very mild immunosuppressive activity and they are often well tolerated with minimal side effects. There are no reports of these medications being associated with an increased risk of infection and studies of large cohorts evaluating the safety profile of 5â€�ASAs do not demonstrate an increased risk of serious or opportunistic infections.<a href="#apt15779-bib-0053"><sup>53</sup></a></p><div class="boxed-text" tagx="boxed-text" title="boxed-text"> <p><b>Sulfasalazine and 5â€�ASA</b></p><ul> <li> <p>Treatment with 5â€�ASA therapy should continue without concern for increased risk of contracting or developing severe COVIDâ€�19.</p> </li> <li> <p>If a patient is in contact with someone who has COVIDâ€�19 or develops COVIDâ€�19, treatment with 5â€�ASA should continue.</p> </li> </ul> <p /> </div> <p /> </div> <div class="corticosteroids" title="sec"><span class="label" tagx="label" title="label">4.2</span><div class="title" tagx="title" title="title">
Corticosteroids</div> <p>Corticosteroids systemically reduce inflammation by turning off multiple inflammatory genes. In patients with COVIDâ€�19, a systemic inflammatory response syndrome can perpetuate lung injury with persistent inflammation resulting in ongoing pulmonary damage even subsequent to viral suppression.<a href="#apt15779-bib-0054"><sup>54</sup></a> Corticosteroids have therefore been trialled in the treatment of coronavirusâ€™, including COVIDâ€�19.<a href="#apt15779-bib-0054"><sup>54</sup></a>, <a href="#apt15779-bib-0055"><sup>55</sup></a>, <a href="#apt15779-bib-0056"><sup>56</sup></a> However corticosteroids in these infections have no demonstrated benefit; rather, steroids have been shown to increase harm in the management of SARS,<a href="#apt15779-bib-0054"><sup>54</sup></a> MERS<a href="#apt15779-bib-0055"><sup>55</sup></a> and influenza.<a href="#apt15779-bib-0056"><sup>56</sup></a> In a retrospective observational study of 309 patients who were critically ill with MERS, the 159 patients who received corticosteroids were more likely to require mechanical ventilation, vasopressors and renal replacement therapy.<a href="#apt15779-bib-0055"><sup>55</sup></a> Furthermore, corticosteroids were not associated with a difference in 90â€�day mortality (adjusted odds ratio 0.8, 95% CI: 0.5â€�1.1, <i>P</i>Â =Â 0.12) but were associated with delayed clearance of viral RNA from respiratory tract secretions (adjusted hazard ratio 0.4, 95% CI 0.2â€�0.7; <i>P</i>Â =Â 0.0005).<a href="#apt15779-bib-0055"><sup>55</sup></a> In SARS, corticosteroid treatment was of no clinical benefit in regard to infection resolution but was associated with an increased risk of psychosis,<a href="#apt15779-bib-0057"><sup>57</sup></a> delayed clearance of viral RNA,<a href="#apt15779-bib-0058"><sup>58</sup></a> diabetes<a href="#apt15779-bib-0059"><sup>59</sup></a> and avascular necrosis.<a href="#apt15779-bib-0060"><sup>60</sup></a> Finally, in a systematic review on corticosteroid treatment in influenza patients, corticosteroids were associated with an increased length of stay in intensive care, an increased rate of secondary bacterial and fungal infections and an increase in mortality compared to those who did not receive corticosteroids.<a href="#apt15779-bib-0056"><sup>56</sup></a> Whether this indicates that those already on steroids for management of other medical illnesses are at increased risk of adverse outcomes with COVIDâ€�19 remains uncertain; however, steroids are widely known to increase the risk of opportunistic infections and respiratory infections including influenza, pneumonia and severe infections and are associated with an increased risk of hospitalisation and mortality in IBD patients, particularly at doses of prednisolone or its equivalent â‰¥20Â mg.<a href="#apt15779-bib-0061"><sup>61</sup></a>, <a href="#apt15779-bib-0062"><sup>62</sup></a>, <a href="#apt15779-bib-0063"><sup>63</sup></a>, <a href="#apt15779-bib-0064"><sup>64</sup></a> Therefore, due to the possible risks with systemic corticosteroids, IBD patients should taper their systemic corticosteroids to the lowest tolerated dose with complete weaning where possible. Patients should also be advised not to selfâ€�commence systemic corticosteroids to control IBD symptoms unless under the direction of their gastroenterologist. Where possible if patients come into contact with a COVIDâ€�19 patient or develop COVIDâ€�19 symptoms they should also taper corticosteroids.</p> <p>Data for budesonide and beclomethasone, locally acting corticosteroids with low systemic bioavailability, demonstrate that these medications are associated with significantly fewer side effects when compared to systemic corticosteroids with adverse events similar to placebo.<a href="#apt15779-bib-0065"><sup>65</sup></a>, <a href="#apt15779-bib-0066"><sup>66</sup></a>, <a href="#apt15779-bib-0067"><sup>67</sup></a>, <a href="#apt15779-bib-0068"><sup>68</sup></a>, <a href="#apt15779-bib-0069"><sup>69</sup></a></p><div class="boxed-text" tagx="boxed-text" title="boxed-text"> <p><b>Corticosteroids</b></p><ul> <li> <p>Corticosteroids (particularly â‰¥20Â mg prednisolone or its equivalent) are associated with an increased risk of infection; however, it is unclear if treatment with corticosteroids is associated with an increased risk of COVIDâ€�19 infection or complications.</p> </li> <li> <p>Where possible, corticosteroid use should be avoided and rapid tapering should be consideredÂ Â±Â switch to budesonide. This must be weighed up against the risk of IBD flare.</p> </li> <li> <p>If a patient requires a course of corticosteroids to treat a flare, consider the use of budesonide or beclomethasone where possible, and in CD, consider exclusive enteral nutrition (EEN) as an alternative induction agent.</p> </li> <li> <p>If a patient is in contact with a person with COVIDâ€�19 or develops COVIDâ€�19, taper corticosteroidsÂ Â±Â switch to budesonide or beclomethasone where possible, but consider need for stressâ€�dose steroids if septic or shocked.</p> </li> </ul> <p /> </div> <p /> </div> <div class="immunomodulators" title="sec"><span class="label" tagx="label" title="label">4.3</span><div class="title" tagx="title" title="title">
Immunomodulators</div> <p>Immunomodulators are commonly used in the management of IBD, as monotherapy or combination therapy, with a view to maintaining remission in isolation or enhancing the pharmacologic profile of the biologics. These agents, previously used predominantly in the chemotherapy and transplant setting, act to alter immune function by causing apoptosis of T cells, integral in host defence against viral pathogens.<a href="#apt15779-bib-0070"><sup>70</sup></a> Thiopurines (azathioprine and mercaptopurine) have been associated with an increased risk of serious and opportunistic infections<a href="#apt15779-bib-0070"><sup>70</sup></a> and appear to reduce immune response to viruses, with their use being associated with up to a fivefold increased risk of herpes simplex virus lesions and significant worsening of viral warts.<a href="#apt15779-bib-0071"><sup>71</sup></a> However there is limited evidence that they increase the risk of either upper respiratory tract infections or pulmonary infections.<a href="#apt15779-bib-0070"><sup>70</sup></a>, <a href="#apt15779-bib-0071"><sup>71</sup></a> In addition, mercaptopurine has been shown to inhibit one of the proteases essential to viral maturation of MERSâ€�CoV in vitro, although no further animalâ€�based models exist to suggest clinical efficacy.<a href="#apt15779-bib-0072"><sup>72</sup></a></p> <p>Methotrexate has variably been demonstrated to increase the risk of infections in patients with inflammatory diseases. Reassuringly, a recent systematic review reassuringly found that in the nonrheumatoid arthritis inflammatory disease population, there was not an increased risk of infection with methotrexate (1.03, 95% CI0.82â€�1.3).<a href="#apt15779-bib-0073"><sup>73</sup></a> This applied similarly to respiratory infections specifically.<a href="#apt15779-bib-0074"><sup>74</sup></a></p><div class="boxed-text" tagx="boxed-text" title="boxed-text"> <p><b>Immunomodulators</b></p><ul> <li> <p>No clear evidence of increased risk of lower respiratory tract infections with immunomodulators</p> </li> <li> <p>Some evidence that thiopurines impair viral immunity and mixed evidence that that they have some antiâ€�viral activity.</p> </li> <li> <p>Weigh risks and benefits, but most patients can continue on stable dose. In older patients, those in sustained remission and with coâ€�morbidities, consider ceasing.</p> </li> <li> <p>Avoid commencing thiopurines or increasing dose: this will allow patients to avoid potential side effects and frequent pathology monitoring.</p> </li> <li> <p>If a patient is in contact with someone with COVIDâ€�19 consider temporarily withholding thiopurines for 2Â weeks.</p> </li> <li> <p>If a patient tests positive for SARSâ€�CoVâ€�2 and/or develops COVIDâ€�19, consider temporarily withholding thiopurines until patient clears infection.</p> </li> </ul> <p /> </div> <p /> </div> <div class="biologics" title="sec"><span class="label" tagx="label" title="label">4.4</span><div class="title" tagx="title" title="title">
Biologics</div> <div class="tnfantagonists" title="sec"><span class="label" tagx="label" title="label">4.4.1</span><div class="title" tagx="title" title="title">
TNF antagonists</div> <p>Antiâ€�TNF agents have been shown to increase the risk of upper and lower respiratory tract infections, as well as serious and opportunistic pulmonary infections.<a href="#apt15779-bib-0062"><sup>62</sup></a>, <a href="#apt15779-bib-0075"><sup>75</sup></a>, <a href="#apt15779-bib-0076"><sup>76</sup></a> Compared with antiâ€�TNF monotherapy, risk of serious infections increases with combination of antiâ€�TNF and an immunosuppressive agent or most significantly in combination with corticosteroids.<a href="#apt15779-bib-0077"><sup>77</sup></a> In a study that did not separate monoâ€"or combinationâ€"antiâ€�TNF therapies, the risk of pneumonia was only slightly increased in patients receiving a TNF antagonist (OR: 1.28, 95% CI [1.08â€�1.52]).<a href="#apt15779-bib-0062"><sup>62</sup></a></p> <p>Of note, antiâ€�TNF therapy has been employed in the management of severe sepsis, with a metaâ€�analysis demonstrating reduced overall mortality when used in severe sepsis before shock, and improved survival at 30Â days in patients with shock or high baseline levels of ILâ€�6.<a href="#apt15779-bib-0078"><sup>78</sup></a> There are no data on the incidence and severity of SARS or COVIDâ€�19 in patients on antiâ€�TNF medications. Antiâ€�TNF agents were utilised in the initial phase of the SARs epidemic, although the overall evidence for efficacy is lacking.<a href="#apt15779-bib-0079"><sup>79</sup></a></p> </div> <div class="biologics:nonâ€�tnfantagonists" title="sec"><span class="label" tagx="label" title="label">4.4.2</span><div class="title" tagx="title" title="title">
Biologics: nonâ€�TNF antagonists</div> <p>The main nonâ€�TNF antagonist biologics for IBD include the antiâ€�IL12/23 biologic ustekinumab and the antiâ€�integrin therapy, vedolizumab. Reassuringly, the risk of severe respiratory tract infections, severe infections in general or opportunistic infections does not appear to be increased in longâ€�term followâ€�up studies of ustekinumab in both IBD and psoriasis.<a href="#apt15779-bib-0080"><sup>80</sup></a>, <a href="#apt15779-bib-0081"><sup>81</sup></a>, <a href="#apt15779-bib-0082"><sup>82</sup></a> Similar data have also been reported for vedolizumab.<a href="#apt15779-bib-0083"><sup>83</sup></a>, <a href="#apt15779-bib-0084"><sup>84</sup></a>, <a href="#apt15779-bib-0085"><sup>85</sup></a>, <a href="#apt15779-bib-0086"><sup>86</sup></a> There is a theoretical concern of an increased risk of respiratory infections, and hence COVIDâ€�19, with vedolizumab treatment as vedolizumab binds the Tâ€�cell integrin receptor Î±<sub>4</sub>Î²<sub>7,</sub> inhibiting its binding to MADCAM1 present on the small intestinal endothelium and vasculature. These receptors are also expressed in the T cells occupying the nares, although to a far lesser extent when compared to the intestine.<a href="#apt15779-bib-0087"><sup>87</sup></a> Reassuringly, a recently conducted network metaâ€�analysis failed to demonstrate a significant difference in rates of nasopharyngitis between antiâ€�TNF agents and vedolizumab, and multiple studies on the safety of vedolizumab have demonstrated that there is no increased risk of respiratory, systemic or serious infections in patients on vedolizumab over placebo .<a href="#apt15779-bib-0083"><sup>83</sup></a>, <a href="#apt15779-bib-0084"><sup>84</sup></a>, <a href="#apt15779-bib-0085"><sup>85</sup></a>, <a href="#apt15779-bib-0086"><sup>86</sup></a></p><div class="boxed-text" tagx="boxed-text" title="boxed-text"> <p><b>Biological therapies</b></p><ul> <li> <p>Biological therapies appear relatively safe.</p> </li> <li> <p>If commencingÂ on a new patient, where appropriate consider subcutaneous dosing mechanism to reduce infusion centre burden/health facility contact.</p> </li> <li> <p>Elective switching from infliximab infusions to subcutaneous antiâ€�TNF formulations is not advised asÂ this may increase the risk of relapse.<a href="#apt15779-bib-0088"><sup>88</sup></a></p> </li> <li> <p>If on combination therapy and patient is in deep remission and/or older, consider withholding/ceasing immunomodulator therapy to reduce infection risk. If possible utilise therapeutic drug monitoring to guide decision.</p> </li> <li> <p>If patient is in contact with someone who has COVIDâ€�19, consider withholding antiâ€�TNF therapies for 2Â weeks. Likely safe to continue other biologics.</p> </li> <li> <p>If patient tests positive for SARSâ€�CoVâ€�2 and/or develops COVIDâ€�19, consider withholding biologics until patient clears infection.</p> </li> </ul> <p /> </div> <p /> </div> </div> <div class="jakinhibitors" title="sec"><span class="label" tagx="label" title="label">4.5</span><div class="title" tagx="title" title="title">
JAK inhibitors</div> <p>Tofacitinib, an orally active Janus kinase (JAK) inhibitor, is employed in the management of UC, particularly in those patients with disease refractory to biologic agents. Tofacitinib may impair immunity to viral infections and has been shown to increase the risk of herpes zoster (HZ) infection, with 5.6% of UC patients developing HZ on longâ€�term extension trials.<a href="#apt15779-bib-0089"><sup>89</sup></a> However, longâ€�term followâ€�up of patients treated with this agent for rheumatoid arthritis have described rates of URTI (18.8%) and nasopharyngitis (14.6%) comparable to that of antiâ€�TNFs.<a href="#apt15779-bib-0090"><sup>90</sup></a> Serious infection was found to be increased with tofacitinib in the induction trials for UC, but similar across treatment groups including placebo in the maintenance trial.<a href="#apt15779-bib-0091"><sup>91</sup></a> Of 4789 patients treated with tofacitinib in phase II, III and LTE studies, 259 patients had serious infections (3.09 events per 100 PY [95% CI 2.73, 3.49]), and the most common infection was pneumonia.<a href="#apt15779-bib-0092"><sup>92</sup></a> Higher doses of 10Â mg twice daily as opposed to 5Â mg twice daily, age &amp;gt;65Â years, corticosteroids &amp;gt;7.5Â mg/d and diabetes were also independent factors associated with increased serious infection risk.<a href="#apt15779-bib-0092"><sup>92</sup></a>, <a href="#apt15779-bib-0093"><sup>93</sup></a> Therefore, patients on tofacitinib should be maintained on the lower 5Â mg twice daily dose compared to 10Â mg twice daily where possible and weaned off corticosteroids.</p> <p>Interestingly, baricitinib, a JAK inhibitor used in rheumatoid arthritis, has a potential therapeutic role in the management of SARSâ€�CoVâ€�2 through both its antiâ€�inflammatory action and Numbâ€�associated kinase (NAK) inhibition. Tofacitinib has no affinity for this particular kinase. NAKs are involved in the function of clathrin, which mediates endocytosis of SARSâ€�CoVâ€�2 into cells resulting in infection.<a href="#apt15779-bib-0094"><sup>94</sup></a> Due to the antiâ€�inflammatory effects of the JAK inhibitors, it has also been speculated that they may be able to combat the elevated levels of cytokines observed in COVIDâ€�19 which may potentially further decrease the severity of the infection.<a href="#apt15779-bib-0094"><sup>94</sup></a></p><div class="boxed-text" tagx="boxed-text" title="boxed-text"> <p><b>JAK inhibitors</b></p><ul> <li> <p>JAK inhibitors may impair viral immunity.</p> </li> <li> <p>Use lowest effective dose to maintain remission: Where possible maintain patients on 5Â mg twice daily as opposed to 10Â mg twice daily.</p> </li> <li> <p>Avoid commencing tofacitinib during pandemic unless there are no other alternatives. This will allow patients to avoid potential side effects and frequent pathology monitoring.</p> </li> <li> <p>If a patient is in contact with someone with COVIDâ€�19, consider temporarily withholding tofacitinib for 2Â weeks.</p> </li> <li> <p>If a patient tests positive for SARSâ€�CoVâ€�2 and/or develops COVIDâ€�19, consider withholding tofacitinib until patient clears the infection.</p> </li> </ul> <p /> </div> <p /> </div> <div class="recommencementofmedicationsfollowingcovidâ€�19infection" title="sec"><span class="label" tagx="label" title="label">4.6</span><div class="title" tagx="title" title="title">
Recommencement of medications following COVIDâ€�19 infection</div> <p>If a patient is exposed to or gets infected with COVIDâ€�19, the withholding of immunosuppressive medications should be considered where possible. Patients exposed to COVIDâ€�19 will usually display symptoms of COVIDâ€�19 within 14Â days and therefore if they remain asymptomatic, recommencement of these medications can occur at this time point. If a patient develops COVIDâ€�19 and has held/delayed their IBD medication, recommencement of medication can occur once the infection has been cleared.</p> <p>To clear a patient of COVIDâ€�19: </p><ol> <li> <p>Where testing is available: patients can be cleared of COVIDâ€�19 if they have clinically recovered and have two negative nasopharyngeal swabs at 24Â hour intervals at least 8Â days after symptom onset.<a href="#apt15779-bib-0095"><sup>95</sup></a></p> </li> <li> <p>Where testing capacity is limited: due to potential prolonged shedding, guidelines suggest an immunocompromised patient should wait at LEAST 14Â days after symptom onset (as opposed to 8Â days in nonâ€�immunocompromised patients) and be cleared if there is clinical improvement in symptoms and complete resolution of fever for at LEAST 3Â days.<a href="#apt15779-bib-0095"><sup>95</sup></a></p> </li> </ol> <p /> <p>It is important to note that many IBD medications may take months to be eliminated from the body so the utility of withholding these medications in the short term is likely to be limited. (See Table <a href="#apt15779-tbl-0003">3</a>).</p> <div class="table-wrap_UNKNOWN" id="apt15779-tbl-0003" content-type="Table" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3</span> <p>Halfâ€�life elimination of IBD medications</p>  <table frame="hsides" rules="groups"> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <thead valign="top"> <tr style="border-bottom:solid 1px #000000"> <th align="left" valign="top" rowspan="1" colspan="1">Drug</th> <th align="left" valign="top" rowspan="1" colspan="1">Halfâ€�life and time to reach therapeutic effect</th> <th align="left" valign="top" rowspan="1" colspan="1">Elimination halfâ€�life (Most drugs considered to have negligible effect after fourâ€�toâ€�five halfâ€�lives)</th> <th align="left" valign="top" rowspan="1" colspan="1"> <p>How long the immunosuppression lasts</p> <p>50% drug eliminated after one elimination halfâ€�lives</p> <p>75% drug eliminated after two elimination halfâ€�lives</p> <p>99% drug eliminated after seven elimination halfâ€�lives</p> </th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">Thiopurines (Azathioprine and Mercaptopurine)</td> <td align="left" rowspan="1" colspan="1"> <p><i>t</i><sub>1/2</sub>:6â€�TGN and 6â€�MMP in RBCÂ =Â 5 days<a href="#apt15779-bib-0124"><sup>124</sup></a></p> <p>Steady state: 6â€�TGN and 6â€�MMPÂ =Â 4Â weeks in RBC<a href="#apt15779-bib-0124"><sup>124</sup></a></p> <p>Median time to clinical response: 4.5 months<a href="#apt15779-bib-0125"><sup>125</sup></a></p> </td> <td align="left" rowspan="1" colspan="1">6â€�TGN in RBC: 6.8Â days [IQR 5.9â€�8.4Â days]<a href="#apt15779-bib-0126"><sup>126</sup></a>, <a href="#apt15779-note-0004"><sup>a</sup></a></td> <td align="left" rowspan="1" colspan="1"> <p>75% of 6â€�TGN eliminated after 10â€�14Â days and expected to be negligible by day 40.<a href="#apt15779-bib-0126"><sup>126</sup></a></p> <p>Immune reconstitution occurs quickly after thiopurine cessation, if the antigen was not encountered whilst on the thiopurine therapy.<a href="#apt15779-bib-0126"><sup>126</sup></a></p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Adalimumab</td> <td align="left" rowspan="1" colspan="1">The subcutaneous injection has a bioavailability of 64% and peak drug concentration at day 5 following injection<a href="#apt15779-bib-0127"><sup>127</sup></a></td> <td align="left" rowspan="1" colspan="1"> <p>17.8â€�23.9Â days (in RA population)<a href="#apt15779-bib-0128"><sup>128</sup></a></p> <p>Clearance of 0.33L/day<a href="#apt15779-bib-0013"><sup>13</sup></a></p> </td> <td align="left" rowspan="1" colspan="1">75% eliminated after approximately 40Â days</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Infliximab</td> <td align="left" rowspan="1" colspan="1">IV infusion 8â€�9.5Â days</td> <td align="left" rowspan="1" colspan="1">7â€�12Â days <a href="#apt15779-bib-0129"><sup>129</sup></a>, <a href="#apt15779-bib-0130"><sup>130</sup></a></td> <td align="left" rowspan="1" colspan="1"> <p>75% eliminated after 2â€�3Â weeks</p> <p>Low volume of distribution (3â€�6L/kg) and very low systemic clearance of 11â€�15ml/hr, mean infliximab is predominantly in the intravascular space for 12â€�17Â days prior to elimination<a href="#apt15779-bib-0129"><sup>129</sup></a>, <a href="#apt15779-bib-0130"><sup>130</sup></a></p> <p>Low albumin and higher body weight will speed up elimination<a href="#apt15779-bib-0131"><sup>131</sup></a></p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Tofacitinib</td> <td align="left" rowspan="1" colspan="1">3â€�3.8Â hours</td> <td align="left" rowspan="1" colspan="1">3Â hours</td> <td align="left" rowspan="1" colspan="1"> <p>After a single dose, 95% is expected to be eliminated within 24Â hours.</p> <p>Pharmacodynamic effects generally reversible in 14Â days after discontinuation</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Methotrexate</td> <td align="left" rowspan="1" colspan="1">Methotrexate in serum has a halfâ€�life of 6Â hours but is converted quickly to methotrexate polyglutamate which is stored for much longer in liver and erythrocytes.<a href="#apt15779-bib-0132"><sup>132</sup></a></td> <td align="left" rowspan="1" colspan="1">3â€�10Â hours (for methotrexate, not activity)</td> <td align="left" rowspan="1" colspan="1">75% of methotrexate eliminated by within 24Â hours but effect continues through active metabolites.</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Ustekinumab</td> <td align="left" rowspan="1" colspan="1">First dose given IV to reach peak concentration</td> <td align="left" rowspan="1" colspan="1">19Â days</td> <td align="left" rowspan="1" colspan="1"> <p>Eliminated at 0.19 L/day (IBD)</p> <p>75% eliminated by 38Â days</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Golimumab</td> <td align="left" rowspan="1" colspan="1">2â€�2.3Â days (RA Populations) <a href="#apt15779-bib-0128"><sup>128</sup></a></td> <td align="left" rowspan="1" colspan="1">14Â days</td> <td align="left" rowspan="1" colspan="1"> <p>Clearance 7.6Â mL/kg/kg</p> <p>75% eliminated by approx. 30Â days</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Vedolizumab</td> <td align="left" rowspan="1" colspan="1">Although given intravenously, clinical effect can takes weeks</td> <td align="left" rowspan="1" colspan="1">25Â days</td> <td align="left" rowspan="1" colspan="1"> <p>Cleared at 0.157 L/day</p> <p>75% eliminated by 50Â days</p> </td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN" id="apt15779-ntgp-0003"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label"><sup>a</sup></span><p>Low numbers, nÂ =Â 9 with missing data.<a href="#apt15779-bib-0126"><sup>126</sup></a></p> </div> </div> <div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">John Wiley &amp;amp; Sons, Ltd</span>, </span><span class="license" title="license"><span class="license-p" title="license-p">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</span></span></div> </div> </div> </div> <div class="nonpharmacologicalrecommendations" title="sec"><span class="label" tagx="label" title="label">5</span><div class="title" tagx="title" title="title">
NONPHARMACOLOGICAL RECOMMENDATIONS</div> <p>The response to COVIDâ€�19 is rapidly evolving and gastroenterologists should regularly review local, institutional and international recommendations. Despite limited data, patients with IBD are theoretically at increased risk of COVIDâ€�19 due to proximity to medical facilities and immunosuppression. There are therefore several recommendations that clinics and patients can implement to reduce risks. </p><ol> <li> <p><i>Optimise health and treat malnutrition:</i> Nutrition should be optimised as malnutrition can disrupt the innate immune response, including complement and mucosal secretory antibody formation, and is associated with increased infection risk in IBD patients.<a href="#apt15779-bib-0096"><sup>96</sup></a> Smoking has been associated with worse outcomes and increased mortality in COVIDâ€�19<a href="#apt15779-bib-0017"><sup>17</sup></a> and therefore patients should be encouraged to quit smoking.</p> </li> <li> <p><i>Immunisation:</i> Immunisation of patients should be strongly encouraged to reduce preventable coâ€�infection with other viruses: Patients should receive pneumococcus (PCV13 and PPSV 23) and influenza (quadrivalent inactivated vaccine) vaccination.</p> </li> <li> <p><i>Reduce transmission:</i> SARSâ€�CoVâ€�2 undergoes humanâ€�toâ€�human transmission and strategies to reduce transmission should be instigated in populations at risk.<a href="#apt15779-bib-0028"><sup>28</sup></a> Patients should wash hands with soap and water for 20Â seconds or use an alcohol rub, practice social distancing by working from home, standing 2Â m apart from people, avoid touching nose, eyes and mouth and avoiding nonâ€�essential travel. <a href="#apt15779-bib-0097"><sup>97</sup></a>, <a href="#apt15779-bib-0098"><sup>98</sup></a></p> </li> <li> <p><i>Avoid healthcare facilities:</i> A large proportion of healthcare workers have been infected with SARSâ€�CoVâ€�2. Hence, it must be anticipated that super spreading within hospitals may occur.<a href="#apt15779-bib-0028"><sup>28</sup></a> Therefore, patients should preferably avoid hospitals and medical facilities. Suitable patients should have appointments via telehealth allowing for reduced exposure of patients and staff alike to COVIDâ€�19.<a href="#apt15779-bib-0099"><sup>99</sup></a> Doctors should attempt to limit nonâ€�urgent pathology requests and avoid commencing thiopurines or tofacitinib that require frequent blood monitoring early on. Finally, elective surgery and endoscopy should be postponed. Only urgent endoscopic procedures should occur and if patients require a procedure they should have prior screening for COVIDâ€�19 if symptomatic. In addition, to limit pharmacy visits and travel on public transport, prescriptions can be changed to a 3â€�month supply or patients can arrange to have medications delivered by post depending on what is available in their local area.</p> </li> <li> <p><i>Infusion centre management: </i>To reduce the risk of transmission within the infusion centre, patients who are presenting for infusions should be contacted 1â€�2 days prior to determine their risk of COVIDâ€�19. This should include screening for COVIDâ€�19 symptoms, confirming no direct contact with a confirmed COVIDâ€�19 case and asking about fluâ€�like symptoms. If they have any risk factor, the infusion should be delayed. On attendance, patients should be reâ€�screened for symptoms and have their temperature checked. Alternate entry points for infusion patients to avoid contact with hospitalised patients should be arranged or where possible the infusion centre can be moved to a â€˜cleanâ€™ COVIDâ€�19 free area. In addition, social distancing between patients chairs should occur and a single nurse per patient arranged to prevent infection spread. Finally, where possible, infliximab infusions should be converted to a 30â€�minute protocol where safe to do so to limit the duration patients are in the infusion centre.<a href="#apt15779-bib-0100"><sup>100</sup></a></p> </li> </ol> <p /> </div> <div class="pharmacologicalmanagementofcovidâ€�19intheibdpatient" title="sec"><span class="label" tagx="label" title="label">6</span><div class="title" tagx="title" title="title">
PHARMACOLOGICAL MANAGEMENT OF COVIDâ€�19 IN THE IBD PATIENT</div> <p>Although there does not appear to be an increased risk of COVIDâ€�19 in patients with IBD, when an IBD patient does develop COVIDâ€�19, there are no therapeutic options approved for the treatment of coronaviruses. Management of COVIDâ€�19 predominantly focuses on supportive care and treating secondary complications.</p> <p>The highly pathogenic nature of COVIDâ€�19 and the need to reduce burden on the health care systems worldwide has encouraged clinicians to examine all possible treatment options. WHO has created a master protocol for a multicentre, adaptive, randomised, double blind placebo controlled trial of the safety and efficacy of investigative therapies for the treatment of COVIDâ€�19.<a href="#apt15779-bib-0101"><sup>101</sup></a> There are many drug trials currently occurring. Evidence behind some of these trials is discussed and possible drug interactions with IBD medications and the most commonly cited experimental COVIDâ€�19 therapies are summarised in TableÂ <a href="#apt15779-tbl-0004">4</a>. Where interactions exist, it is possible for patients to cease their IBD medications and continue on trial medications.</p> <div class="table-wrap_UNKNOWN" id="apt15779-tbl-0004" content-type="Table" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 4A</span> <p>COVIDâ€�19 experimental treatments</p>  <table frame="hsides" rules="groups"> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <thead valign="top"> <tr style="border-bottom:solid 1px #000000"> <th align="left" valign="top" rowspan="1" colspan="1">COVIDâ€�19 treatments</th> <th align="left" valign="top" rowspan="1" colspan="1"><b>Trials</b></th> <th align="left" valign="top" rowspan="1" colspan="1"><b>Interaction potential</b></th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Remdesivir</b></p> <p><b>(GSâ€�5734)</b></p> <p>Adults â‰¥40Â kg: Daily IV dose over 30Â min. Day 1: 200Â mg</p> <p>Day 2â€�10: 100Â mg</p> <p>Paed &amp;lt;40Â kg: Daily IV dose over 30Â min.</p> <p>Day 1: 5Â mg/kg</p> <p>Day 2â€�10: 2.5Â mg/kg</p> </td> <td align="left" rowspan="1" colspan="1"> <p>ClinicalTrials.gov Identifier:</p> <p>NCT04292730</p> <p>NCT04302766</p> <p>NCT04292899</p> </td> <td align="left" rowspan="1" colspan="1"> <p><u>Substrate of</u>: CYP2C8, CYP2D6, CYP3A4, transporters OATP1B1 and Pgp </p><ul> <li><span class="label" tagx="label" title="label">â€�</span><p><b><i>Drugs that are strong inducers will decrease remdesivir effect</i></b></p> </li> </ul> <p /> <p><u>Inhibits</u>: CYP3A4, OATP1B1/3, BSEP, MRP4 and NTCP </p><ul> <li><span class="label" tagx="label" title="label">â€�</span><p><i>unlikely clinically significant</i></p> </li> </ul> <p /> <p><u>Induces</u>: CYP1A2 and CYP2B6 </p><ul> <li><span class="label" tagx="label" title="label">â€�</span><p><i>unlikely clinically significant</i></p> </li> </ul> <p /> <p><i>All in vitro data</i></p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Lopinavir/ Ritonavir (Kaltera) (400Â mg/100Â mg)</b></p> <p>400mg/100mg twice daily for 14 days</p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>Crushing tablet â†" absorption â‰… 45%<sup>133</sup>. Use oral liquid (42.4% alcohol and 15.3% propylene glycol)</p> <p>Use compatible feeding tubes (PVC or silicone) Avoid metronidazole and disulfiram</p> <p>Absorbed in jejunum: NG ok; NJ may â†" effect</p> </td> <td align="left" rowspan="1" colspan="1"> <p>ClinicalTrials.gov Identifier:</p> <p>NCT04276688</p> <p>Chinese Clinical Trials Registry ID:</p> <p>ChiCTR2000029539</p> <p>EU Clinical Trials Register ID:</p> <p>2020â€�000936â€�23</p> </td> <td align="left" rowspan="1" colspan="1"> <p><b>Ritonavir/lopinavir:</b></p> <p>Lopinovir extensively metabolised by CYP3A</p> <p><u>Inhibitor of:</u> CYP3A4 (potent*), Pâ€�gp, BCPR, OATP1B1 </p><ul> <li><span class="label" tagx="label" title="label">â€�</span><p><b><i>can increase concentration of drugs metabolised or substrates of these pathways</i></b></p> </li> </ul> <p /> <p><u>Inducer of</u>: CYP2C9, CYP2C19, glucuronidation</p> <p>Can prolong PR interval.</p> <p>Rare reports of 2<sup>nd</sup> and 3<sup>rd</sup> degree atrioventricular block in patients with underlying risk factors</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Chloroquine/Hydroxychloroquine</b></p> <p>200Â mg three times a day for 10Â days</p> <p><span class="inline-graphic" title="inline-graphic" /></p> </td> <td align="left" rowspan="1" colspan="1"> <p>ClinicalTrials.gov Identifier:</p> <p>NCT04261517</p> <p>Chinese Clinical Trials Registry ID:</p> <p>ChiCTR2000029609</p> </td> <td align="left" rowspan="1" colspan="1"> <p><u>Metabolised by</u>: CYP2C8, CYP3A4, CYP2D6</p> <p><u>Inhibited by:</u> CYP2D6 and Pâ€�gp</p> <p>Can prolong QTc interval, consider ECG monitoring where appropriate</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"><b>Interferon beta</b></td> <td align="left" rowspan="1" colspan="1"> <p>ClinicalTrials.gov Identifier:</p> <p><a href="https://clinicaltrials.gov/ct2/show/NCT04276688?recrs=a&amp;cond=COVID-19&amp;draw=2&amp;rank=47">https://clinicaltrials.gov/ct2/show/NCT04276688?recrs=a&amp;amp;cond=COVID-19&amp;amp;draw=2&amp;amp;rank=47</a></p> </td> <td align="left" rowspan="1" colspan="1"> <p>Interferons have been reported to reduce CYP450 drug metabolism </p><ul> <li><span class="label" tagx="label" title="label">â€�</span><p>care with narrow therapeutic index drugs dependent on CYP450 clearance</p> </li> </ul> <p /> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Ribavirin</b></p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>Do not crush â€"known teratogen.</p> <p>Contact hospital pharmacy for solution compounded from capsules or (SAS) product availability</p> </td> <td align="left" rowspan="1" colspan="1"> <p>ClinicalTrials.gov Identifier:</p> <p><a href="https://clinicaltrials.gov/ct2/show/NCT04276688?recrs=a&amp;cond=COVID-19&amp;draw=2&amp;rank=47">https://clinicaltrials.gov/ct2/show/NCT04276688?recrs=a&amp;amp;cond=COVID-19&amp;amp;draw=2&amp;amp;rank=47</a></p> </td> <td align="left" rowspan="1" colspan="1"> <p>Not metabolised by CYP450 unlikely to contribute to CYP interactions.</p> <p>Inhibits inosine monophosphate dehydrogenase:</p> <p>Can interfere with azathioprine metabolism possibly leading to accumulation of 6â€�methylthioinosine monophosphate (6â€�MTIMP), which has been associated with myelotoxicity</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Favipiravir</b></p> <p><span class="inline-graphic" title="inline-graphic" /></p> </td> <td align="left" rowspan="1" colspan="1"> <p>Chinese Clinical Trials Registry ID:</p> <p>ChiCTR2000029600</p> <p>favipiravir plus interferonâ€�Î±</p> <p>ChiCTR2000029544</p> <p>favipiravir plus baloxavir marboxil</p> </td> <td align="left" rowspan="1" colspan="1"> <p><u>Metabolised by</u>: Nicotinamide adenine dinucleotide phosphate (NADPH) independent and dependent enzymes.</p> <p><u>Inhibits:</u></p> <p>CYP2C8 <i>(strong)</i></p> <p>OAT1, OAT3 (mod)</p> <p>CYP1A2<i>(weak)</i>, CYP2C9<i>(weak)</i>, CYP2C19<i>(weak)</i>, CYP2CD6<i>(weak)</i>, CYP2E1<i>(weak)</i>, CYP3A4<i>(weak)</i></p> <p>Low risk QT prolongation</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Atazanavir</b></p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>Requires pH &amp;lt;4. Avoid antacids 2Â h before and 1 hour after.</p> <p>Food â†‘ bioavailability</p> <p>Absorbed in jejunum: NG ok; NJ may â†" effect</p> </td> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1"> <p><u>Metabolised by</u>: CYP3A4 (extensively)</p> <p><u>Inhibits:</u> CYP3A4, UGT1A1, OATP1B1 (strong), CYP2C8 (weak)</p> <p>Absorption depends on low pH; drugs increasing pH will decrease atazanavir concentration</p> <p>Dose related prolongation in PR interval. Care with drugs increasing QT interval or in patients with preâ€�existing risk factors.</p> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Nitazoxanide (prodrug)</b></p> <p><b>(active metabolite: tizoxanide)</b></p> <p><b>May be dispersible or crushedâ€" check brand</b></p> <p>Take with food â€� increases bioavailability by 50%.</p> </td> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1"> <p>Nil effects on CYP450 enzymes</p> <p>Tizoxanide highly protein bound (&amp;gt;99.9%) </p><ul> <li><span class="label" tagx="label" title="label">â€�</span><p>will compete for binding sites; monitor drugs highly protein bound with a narrow therapeutic index (ie warfarin)</p> </li> </ul> <p /> </td> </tr> <tr> <td align="left" rowspan="1" colspan="1"><b>Tocilizumab (ILâ€�6 monoclonal antibody)</b></td> <td align="left" rowspan="1" colspan="1"> <p>ClinicalTrials.gov Identifier:</p> <p>NCT04310228</p> <p>NCT04306705</p> </td> <td align="left" rowspan="1" colspan="1"> <p>Nil significant drug interactions.</p> <p>COVIDâ€�19 increases ILâ€�6 expression. Tocilizumab reduces ILâ€�6 expression. ILâ€�6 increases CYP3A4, CYP26C19, CYP2C9, CYP1A2. When tocilizumab is used to treat COVIDâ€�19, the effect on drugs effected by these CYP enzymes is unknown.</p> </td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN" id="apt15779-ntgp-0020"> <div class="fn-type-" title=""> <p><span class="inline-graphic" title="inline-graphic" /> Can be crushed; <span class="inline-graphic" title="inline-graphic" /> Can open capsule; <span class="inline-graphic" title="inline-graphic" /> Do not crush; <span class="inline-graphic" title="inline-graphic" /> Liquid product available.</p> </div> </div> <div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">John Wiley &amp;amp; Sons, Ltd</span>, </span><span class="license" title="license"><span class="license-p" title="license-p">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</span></span></div> </div> <div class="table-wrap_UNKNOWN" id="apt15779-tbl-0005" content-type="Table" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 4B</span> <p>Interactions with IBD medications</p>  <table frame="hsides" rules="groups"> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <colgroup><col style="border-right:solid 1px #000000" span="1" /></colgroup> <thead valign="bottom"> <tr style="border-bottom:solid 1px #000000"> <th align="left" rowspan="2" valign="bottom" colspan="1">COVIDâ€�19 treatments</th> <th align="left" colspan="8" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Interactions with IBD treatments</th> </tr> <tr style="border-bottom:solid 1px #000000"> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>Corticosteroids</u></p> <p>Methylprednisolone, Prednisolone, Budesonide, Beclomethasone, Hydrocortisone*#:</p> <p>Metabolised by CYP3A4, CYP3A5*, CYP3A7*</p> <p>Substrate: Pâ€�glycoprotein</p> <p>#Not clinically relevant</p> </th> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>Thiopurines</u> (azathioprine/ mercaptopurine)</p> <p>Metabolised by: TMPT, HGPRT, XO</p> </th> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>Methotrexate</u></p> <p>Transported into the cell by: Reduced folate carrier 1</p> </th> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>Tacrolimus</u></p> <p>Inhibits: CYP3A4 (weak)</p> <p>Metabolised by CYP3A4</p> </th> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>Ciclosporin</u></p> <p>Metabolised by CYP3A4</p> <p>Inhibits: CYP3A4 (moderate),Pâ€�glycoprotein</p> </th> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>Tofacitinib</u></p> <p>Metabolised by CYP3A4 (major) CYP2C19 (minor)</p> </th> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>5ASA</u></p> </th> <th align="left" valign="bottom" rowspan="1" colspan="1"> <p><u>Biologics</u></p> <p>Adalimumab</p> <p>Infliximab</p> <p>Golimumab</p> <p>Vedolizumab</p> <p>Ustekinumab</p> </th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Remdesivir</b></p> <p><b>(GSâ€�5734)</b></p> <p>Adults â‰¥40Â kg: Daily IV dose over 30Â min. Day 1: 200Â mg</p> <p>Day 2â€�10: 100Â mg</p> <p>Paed &amp;lt;40Â kg: Daily IV dose over 30min.</p> <p>Day 1: 5Â mg/kg</p> <p>Day 2â€�10: 2.5Â mg/kg</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Lopinavir/Ritonavir (Kaltera) (400Â mg/100Â mg)</b></p> <p>400Â mg/100Â mg twice daily for 14Â days</p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>Crushing tablet â†" absorption â‰… 45%<a href="#apt15779-bib-0133"><sup>133</sup></a>. Use oral liquid (42.4% alcohol and 15.3% propylene glycol)</p> <p>Use compatible feeding tubes (PVC or silicone) Avoid metronidazole and disulfiram</p> <p>Absorbed in jejunum: NG ok; NJ may â†" effect</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ <b>Methylprednisolone:</b> Consider 50% dose reduction <a href="#apt15779-bib-0124"><sup>124</sup></a>.</p> <p>â†‘ <b>Prednisolone:</b></p> <p>â†" plasma cortisol (level if appropriate)</p> <p>â†‘ <b>Budesonide:</b></p> <p>10â€�20% absorbed<a href="#apt15779-bib-0134"><sup>134</sup></a>. AUC may â†‘ 6.5 fold <a href="#apt15779-bib-0024"><sup>24</sup></a> Consider changing steroid agent or taking budesonide an hour before lopinavir/ritonavir<a href="#apt15779-bib-0124"><sup>124</sup></a></p> <p>â†‘<b>Beclomethasone:</b></p> <p>Despite low bioavailability, increased absorption may occur, monitor for effect<a href="#apt15779-bib-0069"><sup>69</sup></a></p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ Tacrolimus levels: perform levels, consider clinical need and cease</p> <p>â†‘ QT prolongation riskâ€" consider baseline and follow up ECG</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ Ciclosporin levels: monitor levels, consider clinical need and dose reduction</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘Tofacitinib</p> <p>consider clinical need and cease. If necessary, use lowest dose tofacitinib possible</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Chloroquine</b></p> <p><b>/ Hydroxychloroquine</b></p> <p>200Â mg three times a day for 10 days</p> <p><span class="inline-graphic" title="inline-graphic" /></p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘</p> <p>myelosuppression risk. Recommend ceasing thiopurine in acute severe infection</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘</p> <p>myelosuppression risk. Recommend ceasing methotrexate in acute severe infection</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ risk of QTâ€�interval prolongation. consider baseline and follow up ECG</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ ciclosporin levels, perform levels if appropriate</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>May â†‘ tofacitinib, clinical significance unknown.</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"><b>Interferon beta</b></td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>May â†‘ corticosteroid levels, clinical significance unknown, monitor.</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>May â†‘ ciclosporin levels, clinical significance unknown, monitor levels</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>May â†‘ tofacitinib, clinical significance unknown, monitor. Consider lower dose where appropriate</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Ribavirin</b></p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>Do not crush â€"known teratogen.</p> <p>Contact hospital pharmacy for solution compounded from capsules or (SAS) product availability</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ risk of thiopurine induced myelosuppression</p> <p>Cease thiopurine</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ risk myelosuppression</p> <p>Cease methotrexate</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Favipiravir</b></p> <p><span class="inline-graphic" title="inline-graphic" /></p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Atazanavir</b></p> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>Requires pH &amp;lt;4. Avoid antacids 2 hours before and 1 hour after.</p> <p>Food â†‘ bioavailability</p> <p>Absorbed in jejunum: NG ok; NJ may â†" effect</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ <b>Methylprednisolone:</b> Consider 50% dose reduction <a href="#apt15779-bib-0124"><sup>124</sup></a>.</p> <p>â†‘ <b>Prednisolone:</b></p> <p>â†" plasma cortisol (level if appropriate)</p> <p>â†‘ <b>Budesonide:</b></p> <p>10â€�20% absorbed<a href="#apt15779-bib-0134"><sup>134</sup></a>. AUC may â†‘ 6.5 fold <sup>24</sup> Consider changing steroid agent or taking budesonide an hour before lopinavir/ritonavir<a href="#apt15779-bib-0124"><sup>124</sup></a></p> <p>â†‘<b>Beclomethasone:</b></p> <p>Despite low bioavailability, increased absorption may occur, monitor for effect<a href="#apt15779-bib-0069"><sup>69</sup></a></p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ ciclosporin and â†‘ atazanavir.</p> <p>Do not coâ€�administer.</p> </td> <td align="left" rowspan="1" colspan="1"> <p><span class="inline-graphic" title="inline-graphic" /></p> <p>â†‘ tofacitinib, recommend ceasing tofacitinib</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"> <p><b>Nitazoxanide (prodrug)</b></p> <p><b>(active metabolite: tizoxanide)</b></p> <p><b>May be dispersible or crushedâ€" check brand</b></p> <p>Take with food â€� increases bioavailability by 50%.</p> </td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1"><b>Tocilizumab (ILâ€�6 monoclonal antibody)</b></td> <td align="left" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1" /> <td align="left" rowspan="1" colspan="1" /> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN" id="apt15779-ntgp-0030"> <div class="fn-type-" title=""> <p><span class="inline-graphic" title="inline-graphic" /> Can be crushed; <span class="inline-graphic" title="inline-graphic" /> Can open capsule; <span class="inline-graphic" title="inline-graphic" /> Do not crush; <span class="inline-graphic" title="inline-graphic" /> Liquid product available; No clinically significant interaction expected; <span class="inline-graphic" title="inline-graphic" /> Interaction, monitor and dose adjust as required; <span class="inline-graphic" title="inline-graphic" /> Do not administer due to interaction and clinical setting</p> </div> </div> <div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">John Wiley &amp;amp; Sons, Ltd</span>, </span><span class="license" title="license"><span class="license-p" title="license-p">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</span></span></div> </div> <div class="remdesivir(gsâ€�5734)" title="sec"><span class="label" tagx="label" title="label">6.1</span><div class="title" tagx="title" title="title">
Remdesivir (GSâ€�5734)</div> <p>Remdesivir is a prodrug of the adenosine nucleotide analogue GSâ€�441524 that incorporates into nascent viral RNA chains, inhibiting virus infection in a human cell line (human liver cancer Huh 7 cells).<a href="#apt15779-bib-0102"><sup>102</sup></a>, <a href="#apt15779-bib-0103"><sup>103</sup></a> It appears to be effective against RNA viruses SARS, MERS and Ebola.<a href="#apt15779-bib-0103"><sup>103</sup></a> In MERSâ€�CoV mouse models, it has been found to reduce the virus titre and improve lung tissue damage.<a href="#apt15779-bib-0104"><sup>104</sup></a> There are currently multiple phase III studies of remdesivir in COVIDâ€�19 patients.</p> </div> <div class="lopinavir/ritonavir(kaltera;400mg/100mg)" title="sec"><span class="label" tagx="label" title="label">6.2</span><div class="title" tagx="title" title="title">
Lopinavir/ritonavir (Kaltera; 400mg/100mg)</div> <p>Lopinavir/ritonavir combines two protease inhibitors, the latter used to pharmacokinetically â€˜boostâ€™ lopinavir concentrations and prolong the effect through CYP3A4 inhibition.<a href="#apt15779-bib-0104"><sup>104</sup></a> Licensed as an HIV treatment, in vitro and animal model use in SARS and MERSâ€�CoV resulted in a lower risk of ARDS, lower viral load in lung and extrapulmonary tissue and reduced mortality.<a href="#apt15779-bib-0104"><sup>104</sup></a>, <a href="#apt15779-bib-0105"><sup>105</sup></a>, <a href="#apt15779-bib-0106"><sup>106</sup></a> Results from a recent human trial in China did not demonstrate a statistically significant improvement in time to discharge or clinical improvement. However, treatment was commenced late in the diseases course and only in patients who had developed very severe disease.<a href="#apt15779-bib-0107"><sup>107</sup></a> Further trials are needed to determine the utility of this medication regime. Importantly lopinavir/ritonavir inhibits the metabolism of corticosteroids, tacrolimus, ciclosporin and tofacitinib which may lead to toxicity (TableÂ <a href="#apt15779-tbl-0004">4</a>).</p> </div> <div class="chloroquineorhydroxychloroquine" title="sec"><span class="label" tagx="label" title="label">6.3</span><div class="title" tagx="title" title="title">
Chloroquine or hydroxychloroquine</div> <p>Chloroquine is a widely used antiâ€�malarial and autoimmune disease drug. It has a broad spectrum antiâ€�viral action that is exerted on SARSâ€�CoV by inhibiting the preâ€�entry point of the viral cycle by interfering with viral binding to cell surface, increasing endosomal pH required for virus/cell fusion and interfering with the glycosylation of cell surface receptors (ACE 2).<a href="#apt15779-bib-0108"><sup>108</sup></a> It also has immunomodulator properties against many cytokines (ILâ€�1b, ILâ€�1, ILâ€�6, ILâ€�12, TNFâ€�a, INFâ€�a, IFNb, IFNy,) which may enhance its antiâ€�viral effect and reduce COVIDâ€�19 complications synergistically.<a href="#apt15779-bib-0108"><sup>108</sup></a></p> <p>Compared to controls, chloroquine had a superior effect in 100 patients in China infected with COVIDâ€�19 in terms of a reduction in exacerbation of pneumonia, duration of symptoms and delay in viral clearance.<a href="#apt15779-bib-0109"><sup>109</sup></a> Chloroquine is not accessible in Australia and it has been suggested that hydroxychloroquine could be an effective alternative given that it is an identical molecule to chloroquine apart from the addition of a hydroxyl group. <a href="#apt15779-bib-0108"><sup>108</sup></a>, <a href="#apt15779-bib-0110"><sup>110</sup></a> In a French study, 20 COVIDâ€�19 positive patients (&amp;gt;12Â years of age) received hydroxychloroquine 200Â mg three times a day for 10Â days after a mean of 4Â Â±Â 2.6Â days from the onset of symptoms. At day 6, virological clearance was 57% in those receiving hydroxychloroquine compared with 12.5% in the control group (<i>P</i>Â =Â .001). In those who also received azithromycin, virological clearance was 100%.<a href="#apt15779-bib-0111"><sup>111</sup></a> A limitation of this study was the exclusion of patients who discontinued treatment, including three patients who were transferred to ICU. Furthermore, the combination of azithromycin and hydroxychloroquine should be considered with caution given additive potential of QT prolongation. More evidence is required before this treatment can be recommended.</p> </div> <div class="favipiravir(tâ€�705)" title="sec"><span class="label" tagx="label" title="label">6.4</span><div class="title" tagx="title" title="title">
Favipiravir (Tâ€�705)</div> <p>Favipiravir, a guanine analogue, effectively inhibits the RNAâ€�dependent polymerase of RNA viruses. This antiâ€�viral effect has efficacy on influenza (approved use), Ebola, yellow fever, chikungunya, norovirus and enterovirus. Activity against COVIDâ€�19 has been reported.<a href="#apt15779-bib-0112"><sup>112</sup></a> It is currently being tested in Japan and has no significant drug interactions. In a recent study it has been reported to improve clinical recovery rates at day 7 when compared to arbidol, a flu medication (71% vs. 56%) but there was no difference in auxiliary oxygen or nonâ€�invasive ventilation requirements.<a href="#apt15779-bib-0113"><sup>113</sup></a></p> </div> <div class="alternativetherapies" title="sec"><span class="label" tagx="label" title="label">6.5</span><div class="title" tagx="title" title="title">
Alternative therapies</div> <p>Finally, of note as of 12 March 2020, 379 trials for COVIDâ€�19 had been listed on the Chinese Clinical trials Registry; by 15 March 2020 this increased to 420.<a href="#apt15779-bib-0114"><sup>114</sup></a> (TableÂ <a href="#apt15779-sup-0001">S1</a>). Of these trials, 122 (29%) involved the examination of Chinese medicines for the treatment of COVIDâ€�19. As clinicians we need to be aware of the information available to patients seeking â€˜naturalâ€™ alternative therapies and in the absence of clinical evidence, care should be taken when making such suggestions to alleviate panic and inappropriate prescribing.</p> </div> </div> <div class="summary" title="summary"><span class="label" tagx="label" title="label">7</span><div class="title" tagx="title" title="title">
SUMMARY</div> <p>IBD patients present a unique challenge in the setting of the current COVIDâ€�19 pandemic. Of concern is that, at least theoretically, many medications used to treat IBD may result in a degree of immunosuppression and this may lead to an increased risk of infection with SARSâ€�CoVâ€�2 and complications arising from COVIDâ€�19. Despite this, global registries and reports are reassuring and there does not appear to be a signal that IBD patients are at greater risk or severe COVIDâ€�19 compared to the general population. These guidelines summarise the treatment approach to IBD patients in the current climate and emphasises the importance of avoiding corticosteroids and maintaining remission by encouraging compliance with patientsâ€™ usual maintenance medications. If an IBD patient does develop COVIDâ€�19, immunosuppressive medications should be withheld where possible until infection resolution and if a medication trial is being considered and patients remain on IBD medications, interactions with current IBD medications should be evaluated.</p> </div> <div class="authorship" title="sec"> <div class="title" tagx="title" title="title">
AUTHORSHIP</div> <p><i>Guarantor of the article</i>: Britt Christensen.</p> <p><i>Author contributions</i>: Aysha H. Alâ€�Ani, Ralley E. Prentice and ClarissaÂ A. Rentsch reviewed the literature, provided the analysis and drafted the manuscript. Doug Johnson helped to develop the concept of paper, provided ID advice on COVID and its risk and reviewed the manuscript. Zaid Ardalan, Neel Heerasing, Mayur Garg and Finlay A. Macrae contributed to the writing and revision of the manuscript. Sian Campbell and Joe SasadeuszÂ were involved in the literature review, drafting of COVID medical therapies section and revision of manuscript. Siew C. Ng and David T. Rubin helped to develop the concept and revision of manuscript. Britt Christensen designed the study, led the analysis and interpretation of data, andÂ coordinated the writing and revision of manuscript.</p> <p>All the authors approved the final version of the manuscript.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supporting information</div> <div class="local-data" title="local-data">  <p>Table S1</p>  <div class="media" title="media"><a href="APT-9999-na-s001.docx">LINK</a> <p>Click here for additional data file.</p>  </div> </div> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
ACKNOWLEDGEMENTS</div> <p><i>Declaration of personal interests</i>: Aysha H. Alâ€�Ani, Ralley E. Prentice, Zaid Ardalan, Neel Heerasing, Sian Cambell: None. Clarissa A. Rentsch and Doug Johnson have served as speakers for Pfizer. Mayur Garg has served on the advisory board of Pfizer and Pharmacosmos and has received speaker fees, research or travel grants from Abbvie, Janssen, Pfizer, Pharmacosmos, Shire, Takeda and Vifor. Joe Sasadeusz has received research funding from Gilead. Finlay A. Macrae has served as anÂ advisory board member for Rhythm BioSciences, Endogene, Glutagen, and has received research funding from Rhythm Biosciences for clinical trial support in biomarkers of colorectal cancer research. Finlay A. MacraeÂ owns stocks and shares in a superannuation portfolio with to his knowledge no relationship with the current paper. Siew C. Ng has received search grants from Ferring and Abbvie and speakers honorarium from Janssen, Abbvie, Tillotts, Takeda, Olympus and Ferring. David T. Rubin reports grants and personal fees from Abbvie, personal fees from Abgenomics, personal fees from Allergan Inc, personal fees from Boehringer Ingelheim Ltd, personal fees from Bristolâ€�Myers Squibb, personal fees from Celgene Corp/Syneos, personal fees from Checkâ€�cap, personal fees from Dizal Pharmaceuticals, personal fees from GalenPharma/Atlantica, grants and personal fees from Genentech/Roche, personal fees from Gilead Sciences, personal fees from Ichnos Sciences, personal fees from GlaxoSmithKline Group, grants and personal fees from Janssen Pharmaceuticals, personal fees from Lilly, personal fees from Narrow River Mgmt, personal fees from Pfizer, grants and personal fees from Prometheus Laboratories, personal fees from Reistone, grants and personal fees from Shire, grants and personal fees from Takeda, personal fees from Techlab, Inc, outside the submitted work. Britt Christensen has received speaking fees from Abbvie, Jannsen, Pfizer, Takeda and Ferring, research grants from Janssen and Ferring Pharmaceuticals and served on the advisory board of Gilead and Novartis.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="apt15779-bib-0001" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusâ€�infected pneumonia in Wuhan, China</span>. <span class="source" tagx="source" title="source">JAMA</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0002" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: World Health Organisation</span> . <span class="mixed-article-title" title="mixed-article-title">WHO Directorâ€�General's opening remarks at the media briefing on COVIDâ€�19â€"11 March 2020</span>. March 16, 2020. <a href="https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2013-11-march-2020">https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2013-11-march-2020</a>.</span></li> <li tag="ref"><a name="apt15779-bib-0003" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">To</span><span class="given-names" tagx="given-names" title="given-names">Kâ€�W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tse</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Interspecies transmission and emergence of novel viruses: lessons from bats and birds</span>. <span class="source" tagx="source" title="source">Trends Microbiol</span>. <span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">544</span>â€"<span class="lpage" tagx="lpage" title="lpage">555</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23770275">23770275</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0004" /><span class="label" tagx="label" title="label">4</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ghosh</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Premchand</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>. <span class="mixed-article-title" title="mixed-article-title">A UK cost of care model for inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Frontline Gastroenterol</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">169</span>â€"<span class="lpage" tagx="lpage" title="lpage">174</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28839807">28839807</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0005" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">DY</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Son</span><span class="given-names" tagx="given-names" title="given-names">MJ</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Induction and maintenance treatment of inflammatory bowel disease: a comprehensive review</span>. <span class="source" tagx="source" title="source">Autoimmun Rev</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">18</span>:<span class="fpage" tagx="fpage" title="fpage">439</span>â€"<span class="lpage" tagx="lpage" title="lpage">454</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30844556">30844556</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0006" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rahier</span><span class="given-names" tagx="given-names" title="given-names">JF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Magro</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Abreu</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Second European evidenceâ€�based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">J Crohns Colitis</span>. <span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">443</span>â€"<span class="lpage" tagx="lpage" title="lpage">468</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24613021">24613021</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0007" /><span class="label" tagx="label" title="label">7</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Weiss</span><span class="given-names" tagx="given-names" title="given-names">SR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Navasâ€�Martin</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>. <span class="mixed-article-title" title="mixed-article-title">Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus</span>. <span class="source" tagx="source" title="source">Microbiol Mol Biol Rev</span>. <span class="year" tagx="year" title="year">2005</span>;<span class="volume" tagx="volume" title="volume">69</span>:<span class="fpage" tagx="fpage" title="fpage">635</span>â€"<span class="lpage" tagx="lpage" title="lpage">664</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16339739">16339739</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0008" /><span class="label" tagx="label" title="label">8</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cavanagh</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>. <span class="mixed-article-title" title="mixed-article-title">The molecular biology of coronaviruses</span>. <span class="source" tagx="source" title="source">Adv Virus Res</span>. <span class="year" tagx="year" title="year">1997</span>;<span class="volume" tagx="volume" title="volume">48</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">100</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9233431">9233431</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0009" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Su</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Epidemiology, genetic recombination, and pathogenesis of coronaviruses</span>. <span class="source" tagx="source" title="source">Trends Microbiol</span>. <span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">24</span>(<span class="issue" tagx="issue" title="issue">6</span>):<span class="fpage" tagx="fpage" title="fpage">490</span>â€"<span class="lpage" tagx="lpage" title="lpage">502</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27012512">27012512</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0010" /><span class="label" tagx="label" title="label">10</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Monto</span><span class="given-names" tagx="given-names" title="given-names">AS</span></span>. <span class="mixed-article-title" title="mixed-article-title">Medical reviews. Coronaviruses</span>. <span class="source" tagx="source" title="source">Yale J Biol Med</span>. <span class="year" tagx="year" title="year">1974</span>;<span class="volume" tagx="volume" title="volume">47</span>:<span class="fpage" tagx="fpage" title="fpage">234</span>â€"<span class="lpage" tagx="lpage" title="lpage">251</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/4617423">4617423</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0011" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: Centres for Disease Control and Prevention</span> . <span class="mixed-article-title" title="mixed-article-title">Middle East Respiratory Syndrome (MERS)</span>. 2016 Updated August 2, 2019. <a href="https://www.cdc.gov/sars/index.html">https://www.cdc.gov/sars/index.html</a></span></li> <li tag="ref"><a name="apt15779-bib-0012" /><span class="label" tagx="label" title="label">12</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: Centres for Disease Control and Prevention</span> . <span class="mixed-article-title" title="mixed-article-title">Severe Acute Respiratory Syndrome (SARS)</span>. <a href="https://www.cdc.gov/sars/index.html">https://www.cdc.gov/sars/index.html</a>. Accessed 15 March, 2020.</span></li> <li tag="ref"><a name="apt15779-bib-0013" /><span class="label" tagx="label" title="label">13</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Stratton</span><span class="given-names" tagx="given-names" title="given-names">CW</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">YW</span></span>. <span class="mixed-article-title" title="mixed-article-title">Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle</span>. <span class="source" tagx="source" title="source">J Med Virol</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">92</span>:<span class="fpage" tagx="fpage" title="fpage">401</span>â€"<span class="lpage" tagx="lpage" title="lpage">402</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31950516">31950516</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0014" /><span class="label" tagx="label" title="label">14</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kok</span><span class="given-names" tagx="given-names" title="given-names">Kâ€�H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Genomic characterization of the 2019 novel humanâ€�pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</span>. <span class="source" tagx="source" title="source">Emerg Microbes Infect</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">221</span>â€"<span class="lpage" tagx="lpage" title="lpage">236</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31987001">31987001</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0015" /><span class="label" tagx="label" title="label">15</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>. <span class="mixed-article-title" title="mixed-article-title">Probable pangolin origin of SARSâ€�CoVâ€�2 associated with the COVIDâ€�19 outbreak</span>. <span class="source" tagx="source" title="source">Curr Biol</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0016" /><span class="label" tagx="label" title="label">16</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: World Health Organisation</span> . <span class="mixed-article-title" title="mixed-article-title">Report of the WHOâ€�China Joint Mission on Coronavirus Disease 2019 (COVIDâ€�19)</span>. March 16, 2020. <a href="https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf">https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf</a></span></li> <li tag="ref"><a name="apt15779-bib-0017" /><span class="label" tagx="label" title="label">17</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">WJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ni</span><span class="given-names" tagx="given-names" title="given-names">ZY</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of coronavirus disease 2019 in China</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0018" /><span class="label" tagx="label" title="label">18</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>. <span class="mixed-article-title" title="mixed-article-title">COVIDâ€�19: Gastrointestinal manifestations and potential fecalâ€�oral transmission</span>. <span class="source" tagx="source" title="source">Gastroenterology</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0019" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rong</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nian</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>. <span class="mixed-article-title" title="mixed-article-title">Review article: gastrointestinal features in COVIDâ€�19 and the possibility of faecal transmission</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">51</span>:<span class="fpage" tagx="fpage" title="fpage">843</span>â€"<span class="lpage" tagx="lpage" title="lpage">851</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32222988">32222988</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0020" /><span class="label" tagx="label" title="label">20</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Diao</span><span class="given-names" tagx="given-names" title="given-names">MengYuan</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Estimation of the reproductive number of novel coronavirus (COVIDâ€�19) and the probable outbreak size on the Diamond Princess cruise ship: a dataâ€�driven analysis</span>. <span class="source" tagx="source" title="source">Int J Infect Dis</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">93</span>:<span class="fpage" tagx="fpage" title="fpage">201</span>â€"<span class="lpage" tagx="lpage" title="lpage">204</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32097725">32097725</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0021" /><span class="label" tagx="label" title="label">21</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hoffmann</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kleineâ€�Weber</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schroeder</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">SARSâ€�CoVâ€�2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</span>. <span class="source" tagx="source" title="source">Cell</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0022" /><span class="label" tagx="label" title="label">22</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">HKZ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gong</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>.<span class="mixed-article-title" title="mixed-article-title">The digestive system is a potential route of 2019â€�nCov infection: a bioinformatics analysis based on singleâ€�cell transcriptomes</span>. <a href="https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1">https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1</a>. March 16, 2020.</span></li> <li tag="ref"><a name="apt15779-bib-0023" /><span class="label" tagx="label" title="label">23</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Garg</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Royce</span><span class="given-names" tagx="given-names" title="given-names">SG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tikellis</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Imbalance of the reninâ€�angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?</span><span class="source" tagx="source" title="source">Gut</span>. <span class="year" tagx="year" title="year">2019</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0024" /><span class="label" tagx="label" title="label">24</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Clinical course and risk factors for mortality of adult inpatients with COVIDâ€�19 in Wuhan, China: a retrospective cohort study</span>. <span class="source" tagx="source" title="source">Lancet</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">395</span>:<span class="fpage" tagx="fpage" title="fpage">1054</span>â€"<span class="lpage" tagx="lpage" title="lpage">1062</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171076">32171076</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0025" /><span class="label" tagx="label" title="label">25</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Prescott</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Falzarano</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">de Wit</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Pathogenicity and viral shedding of MERSâ€�CoV in immunocompromised rhesus macaques</span>. <span class="source" tagx="source" title="source">Front Immunol</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">205</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29483914">29483914</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0026" /><span class="label" tagx="label" title="label">26</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Eichenberger</span><span class="given-names" tagx="given-names" title="given-names">EM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Soave</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zappetti</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients</span>. <span class="source" tagx="source" title="source">Bone Marrow Transplant</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">54</span>(<span class="issue" tagx="issue" title="issue">7</span>):<span class="fpage" tagx="fpage" title="fpage">1058</span>â€"<span class="lpage" tagx="lpage" title="lpage">1066</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30385869">30385869</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0027" /><span class="label" tagx="label" title="label">27</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">WÃ¶lfel</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Corman</span><span class="given-names" tagx="given-names" title="given-names">VM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Guggemos</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Virological assessment of hospitalized patients with COVIDâ€�2019</span>. <span class="source" tagx="source" title="source">Nature</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0028" /><span class="label" tagx="label" title="label">28</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rothe</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schunk</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sothmann</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Transmission of 2019â€�nCoV infection from an asymptomatic contact in Germany</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">382</span>:<span class="fpage" tagx="fpage" title="fpage">970</span>â€"<span class="lpage" tagx="lpage" title="lpage">971</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32003551">32003551</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0029" /><span class="label" tagx="label" title="label">29</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Evidence for gastrointestinal infection of SARSâ€�CoVâ€�2</span>. <span class="source" tagx="source" title="source">Gastroenterology</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">158</span>:<span class="fpage" tagx="fpage" title="fpage">1831</span>â€"<span class="lpage" tagx="lpage" title="lpage">1833</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32142773">32142773</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0030" /><span class="label" tagx="label" title="label">30</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pan</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mu</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of COVIDâ€�19 patients with digestive symptoms in Hubei, China</span>. <span class="source" tagx="source" title="source">Am J Gastroenterol</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">115</span>:<span class="fpage" tagx="fpage" title="fpage">766</span>â€"<span class="lpage" tagx="lpage" title="lpage">773</span> (In Press).<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32287140">32287140</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0031" /><span class="label" tagx="label" title="label">31</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Carvalho</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Alqusairi</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Adams</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">SARSâ€�CoVâ€�2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVIDâ€�19 disease</span>. <span class="source" tagx="source" title="source">Am J Gastroenterol</span>. <span class="year" tagx="year" title="year">2020</span>;In Press.</span></li> <li tag="ref"><a name="apt15779-bib-0032" /><span class="label" tagx="label" title="label">32</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">van Doremalen</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bushmaker</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Morris</span><span class="given-names" tagx="given-names" title="given-names">DH</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Aerosol and surface stability of SARSâ€�CoVâ€�2 as compared with SARSâ€�CoVâ€�1</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0033" /><span class="label" tagx="label" title="label">33</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: The Lancet</span> . <span class="mixed-article-title" title="mixed-article-title">COVIDâ€�19: protecting healthâ€�care workers</span>. <span class="source" tagx="source" title="source">Lancet</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">395</span>:<span class="fpage" tagx="fpage" title="fpage">922</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0034" /><span class="label" tagx="label" title="label">34</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lauer</span><span class="given-names" tagx="given-names" title="given-names">SA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Grantz</span><span class="given-names" tagx="given-names" title="given-names">KH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bi</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">The incubation period of coronavirus disease 2019 (COVIDâ€�19) from publicly reported confirmed cases: estimation and application</span>. <span class="source" tagx="source" title="source">Ann Intern Med</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">172</span>:<span class="fpage" tagx="fpage" title="fpage">577</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32150748">32150748</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0035" /><span class="label" tagx="label" title="label">35</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Early transmission dynamics in Wuhan, China, of novel coronavirusâ€�infected pneumonia</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0036" /><span class="label" tagx="label" title="label">36</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McGoogan</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>. <span class="mixed-article-title" title="mixed-article-title">Characteristics of and important lessons from the coronavirus disease 2019 (COVIDâ€�19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention</span>. <span class="source" tagx="source" title="source">JAMA</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0037" /><span class="label" tagx="label" title="label">37</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Brake</span><span class="given-names" tagx="given-names" title="given-names">SJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Barnsley</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Smoking upregulates angiotensinâ€�converting enzymeâ€�2 receptor: a potential adhesion site for novel coronavirus SARSâ€�CoVâ€�2 (Covidâ€�19)</span>. <span class="source" tagx="source" title="source">J Clin Med</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">841</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0038" /><span class="label" tagx="label" title="label">38</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kok</span><span class="given-names" tagx="given-names" title="given-names">Kâ€�H</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personâ€�toâ€�person transmission: a study of a family cluster</span>. <span class="source" tagx="source" title="source">Lancet</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">395</span>:<span class="fpage" tagx="fpage" title="fpage">514</span>â€"<span class="lpage" tagx="lpage" title="lpage">523</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31986261">31986261</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0039" /><span class="label" tagx="label" title="label">39</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mo</span><span class="given-names" tagx="given-names" title="given-names">XI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Epidemiology of COVIDâ€�19 among children in China</span>. <span class="source" tagx="source" title="source">Pediatrics</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0040" /><span class="label" tagx="label" title="label">40</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hakki</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rattray</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Press</span><span class="given-names" tagx="given-names" title="given-names">RD</span></span>. <span class="mixed-article-title" title="mixed-article-title">The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients</span>. <span class="source" tagx="source" title="source">J Clin Virol</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">68</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26071326">26071326</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0041" /><span class="label" tagx="label" title="label">41</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Toruner</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Loftus</span><span class="given-names" tagx="given-names" title="given-names">EV</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Harmsen</span><span class="given-names" tagx="given-names" title="given-names">WS</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Risk factors for opportunistic infections in patients with inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Gastroenterology</span>. <span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">134</span>:<span class="fpage" tagx="fpage" title="fpage">929</span>â€"<span class="lpage" tagx="lpage" title="lpage">936</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18294633">18294633</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0042" /><span class="label" tagx="label" title="label">42</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tosca</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Garcia</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pascual</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Clinical assessment of risk factors for infection in inflammatory bowel disease patients</span>. <span class="source" tagx="source" title="source">Int J Colorectal Dis</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">35</span>:<span class="fpage" tagx="fpage" title="fpage">491</span>â€"<span class="lpage" tagx="lpage" title="lpage">500</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31915983">31915983</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0043" /><span class="label" tagx="label" title="label">43</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Aberra</span><span class="given-names" tagx="given-names" title="given-names">FN</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lichtenstein</span><span class="given-names" tagx="given-names" title="given-names">GR</span></span>. <span class="mixed-article-title" title="mixed-article-title">Methods to avoid infections in patients with inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Inflamm Bowel Dis</span>. <span class="year" tagx="year" title="year">2005</span>;<span class="volume" tagx="volume" title="volume">11</span>:<span class="fpage" tagx="fpage" title="fpage">685</span>â€"<span class="lpage" tagx="lpage" title="lpage">695</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15973124">15973124</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0044" /><span class="label" tagx="label" title="label">44</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wisniewski</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kirchgesner</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Seksik</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines</span>. <span class="source" tagx="source" title="source">United European Gastroenterology Journal</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="fpage" tagx="fpage" title="fpage">2050640619889763</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0045" /><span class="label" tagx="label" title="label">45</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Grant</span><span class="given-names" tagx="given-names" title="given-names">WB</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lahore</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McDonnell</span><span class="given-names" tagx="given-names" title="given-names">SL</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Evidence that vitamin D supplementation could reduce risk of influenza and COVIDâ€�19 infections and deaths</span>. <span class="source" tagx="source" title="source">Nutrients</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">988</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0046" /><span class="label" tagx="label" title="label">46</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Panarese</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shahini</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>. <span class="mixed-article-title" title="mixed-article-title">Letter: Covidâ€�19, and vitamin D</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">51</span>:<span class="fpage" tagx="fpage" title="fpage">993</span>â€"<span class="lpage" tagx="lpage" title="lpage">995</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32281109">32281109</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0047" /><span class="label" tagx="label" title="label">47</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rong</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>. <span class="mixed-article-title" title="mixed-article-title">Letter: Covidâ€�19 and vitamin Dâ€�authors' reply</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">51</span>:<span class="fpage" tagx="fpage" title="fpage">995</span>â€"<span class="lpage" tagx="lpage" title="lpage">996</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32286694">32286694</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0048" /><span class="label" tagx="label" title="label">48</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ning</span><span class="given-names" tagx="given-names" title="given-names">LongGui</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shan</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Quantitative proteomic analysis reveals the deregulation of nicotinamide adenine dinucleotide metabolism and CD38 in inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Biomed Res Int</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">2019</span>:<span class="fpage" tagx="fpage" title="fpage">3950628</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31179321">31179321</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0049" /><span class="label" tagx="label" title="label">49</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">An</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Menguao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Megyao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Protection of 318 inflammatory bowel disease patients from the outbreak and rapid spread of COVIDâ€�19 infection in Wuhan, China</span>. <span class="source" tagx="source" title="source">Lancet</span>. <span class="year" tagx="year" title="year">2020</span> (In Press).</span></li> <li tag="ref"><a name="apt15779-bib-0050" /><span class="label" tagx="label" title="label">50</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Brenner</span><span class="given-names" tagx="given-names" title="given-names">EJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ungaro</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Colombel</span><span class="given-names" tagx="given-names" title="given-names">JF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kappelman</span><span class="given-names" tagx="given-names" title="given-names">MD</span></span>.<span class="mixed-article-title" title="mixed-article-title">Secureâ€�IBD Database Public Data Update 2020</span>. <a href="https://covidibd.org/">https://covidibd.org/</a></span></li> <li tag="ref"><a name="apt15779-bib-0051" /><span class="label" tagx="label" title="label">51</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Duan</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, et al. Clinical characteristics of COVIDâ€�19 patients with digestive symptoms in Hubei, China. Am J Gastroenterol. <span class="year" tagx="year" title="year">2020</span>; EPub Ahead of Print.</span></li> <li tag="ref"><a name="apt15779-bib-0052" /><span class="label" tagx="label" title="label">52</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: Centers for Disease Control and Prevention</span> . <span class="mixed-article-title" title="mixed-article-title">Testing for COVIDâ€�19</span>. <a href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html?CDC_AA_refVal=https%253A%252F%252Fwww.cdc.gov%252Fcoronavirus%252F2019-ncov%252Fclinical-criteria.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html?CDC_AA_refVal=https%253A%252F%252Fwww.cdc.gov%252Fcoronavirus%252F2019-ncov%252Fclinical-criteria.html</a>. Accessed March 18, 2020.</span></li> <li tag="ref"><a name="apt15779-bib-0053" /><span class="label" tagx="label" title="label">53</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ransford</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Langman</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>. <span class="mixed-article-title" title="mixed-article-title">Sulphasalazine and mesalazine: serious adverse reactions reâ€�evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines</span>. <span class="source" tagx="source" title="source">Gut</span>. <span class="year" tagx="year" title="year">2002</span>;<span class="volume" tagx="volume" title="volume">51</span>:<span class="fpage" tagx="fpage" title="fpage">536</span>â€"<span class="lpage" tagx="lpage" title="lpage">539</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12235076">12235076</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0054" /><span class="label" tagx="label" title="label">54</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Stockman</span><span class="given-names" tagx="given-names" title="given-names">LJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bellamy</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Garner</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>. <span class="mixed-article-title" title="mixed-article-title">SARS: systematic review of treatment effects</span>. <span class="source" tagx="source" title="source">PLoS Med</span>. <span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">e343</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16968120">16968120</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0055" /><span class="label" tagx="label" title="label">55</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Arabi</span><span class="given-names" tagx="given-names" title="given-names">YM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mandourah</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Alâ€�Hameed</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Corticosteroid therapy for critically Ill patients with middle east respiratory syndrome</span>. <span class="source" tagx="source" title="source">Am J Respir Crit Care Med</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">197</span>:<span class="fpage" tagx="fpage" title="fpage">757</span>â€"<span class="lpage" tagx="lpage" title="lpage">767</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29161116">29161116</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0056" /><span class="label" tagx="label" title="label">56</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ni</span><span class="given-names" tagx="given-names" title="given-names">Yâ€�N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and metaâ€�analysis</span>. <span class="source" tagx="source" title="source">Crit Care</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">99</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30917856">30917856</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0057" /><span class="label" tagx="label" title="label">57</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">DTS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wing</span><span class="given-names" tagx="given-names" title="given-names">YK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Leung</span><span class="given-names" tagx="given-names" title="given-names">HCM</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Factors associated with psychosis among patients with severe acute respiratory syndrome: a caseâ€�control study</span>. <span class="source" tagx="source" title="source">Clin Infect Dis</span>. <span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">39</span>:<span class="fpage" tagx="fpage" title="fpage">1247</span>â€"<span class="lpage" tagx="lpage" title="lpage">1249</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15486852">15486852</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0058" /><span class="label" tagx="label" title="label">58</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Allen Chan</span><span class="given-names" tagx="given-names" title="given-names">KC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hui</span><span class="given-names" tagx="given-names" title="given-names">DS</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Effects of early corticosteroid treatment on plasma SARSâ€�associated Coronavirus RNA concentrations in adult patients</span>. <span class="source" tagx="source" title="source">J Clin Virol</span>. <span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">304</span>â€"<span class="lpage" tagx="lpage" title="lpage">309</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15494274">15494274</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0059" /><span class="label" tagx="label" title="label">59</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">JZ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Glucocorticoidâ€�induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy</span>. <span class="source" tagx="source" title="source">Zhonghua Nei Ke Za Zhi</span>. <span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">43</span>:<span class="fpage" tagx="fpage" title="fpage">179</span>â€"<span class="lpage" tagx="lpage" title="lpage">182</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15059370">15059370</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0060" /><span class="label" tagx="label" title="label">60</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>. <span class="mixed-article-title" title="mixed-article-title">Relationship between glucocorticoid receptor and deficiency syndrome and the regulation of traditional Chinese medicine</span>. <span class="source" tagx="source" title="source">Zhong Xi Yi Jie He Xue Bao</span>. <span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">2</span>:<span class="fpage" tagx="fpage" title="fpage">172</span>â€"<span class="lpage" tagx="lpage" title="lpage">174</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15339435">15339435</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0061" /><span class="label" tagx="label" title="label">61</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tinsley</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Navabi</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Williams</span><span class="given-names" tagx="given-names" title="given-names">ED</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Increased risk of influenza and influenzaâ€�related complications among 140,480 patients with inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Inflamm Bowel Dis</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">25</span>:<span class="fpage" tagx="fpage" title="fpage">369</span>â€"<span class="lpage" tagx="lpage" title="lpage">376</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30020478">30020478</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0062" /><span class="label" tagx="label" title="label">62</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Long</span><span class="given-names" tagx="given-names" title="given-names">MD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Martin</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sandler</span><span class="given-names" tagx="given-names" title="given-names">RS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kappelman</span><span class="given-names" tagx="given-names" title="given-names">MD</span></span>. <span class="mixed-article-title" title="mixed-article-title">Increased risk of pneumonia among patients with inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Am J Gastroenterol</span>. <span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">108</span>:<span class="fpage" tagx="fpage" title="fpage">240</span>â€"<span class="lpage" tagx="lpage" title="lpage">248</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23295276">23295276</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0063" /><span class="label" tagx="label" title="label">63</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Orlicka</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Barnes</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Culver</span><span class="given-names" tagx="given-names" title="given-names">EL</span></span>. <span class="mixed-article-title" title="mixed-article-title">Prevention of infection caused by immunosuppressive drugs in gastroenterology</span>. <span class="source" tagx="source" title="source">Ther Adv Chronic Dis</span>. <span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">4</span>:<span class="fpage" tagx="fpage" title="fpage">167</span>â€"<span class="lpage" tagx="lpage" title="lpage">185</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23819020">23819020</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0064" /><span class="label" tagx="label" title="label">64</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dorrington</span><span class="given-names" tagx="given-names" title="given-names">AM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Selinger</span><span class="given-names" tagx="given-names" title="given-names">CP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Parkes</span><span class="given-names" tagx="given-names" title="given-names">GC</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">The historical role and contemporary use of corticosteroids in inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">J Crohns Colitis</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0065" /><span class="label" tagx="label" title="label">65</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sherlock</span><span class="given-names" tagx="given-names" title="given-names">ME</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Seow</span><span class="given-names" tagx="given-names" title="given-names">CH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Steinhart</span><span class="given-names" tagx="given-names" title="given-names">AH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Griffiths</span><span class="given-names" tagx="given-names" title="given-names">AM</span></span>. <span class="mixed-article-title" title="mixed-article-title">Oral budesonide for induction of remission in ulcerative colitis</span>. <span class="source" tagx="source" title="source">Cochrane Database Syst Rev</span>. <span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">CD007698</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0066" /><span class="label" tagx="label" title="label">66</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Benchimol</span><span class="given-names" tagx="given-names" title="given-names">EI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Seow</span><span class="given-names" tagx="given-names" title="given-names">CH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Otley</span><span class="given-names" tagx="given-names" title="given-names">AR</span></span>. <span class="mixed-article-title" title="mixed-article-title">Steinhart AH. Budesonide for maintenance of remission in Crohn's disease</span>. <span class="source" tagx="source" title="source">Cochrane Database Syst Rev</span>. <span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">1</span>:<span class="fpage" tagx="fpage" title="fpage">CD002913</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0067" /><span class="label" tagx="label" title="label">67</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Manguso</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bennato</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lombardi</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Efficacy and safety of oral beclomethasone dipropionate in ulcerative colitis: a systematic review and metaâ€�analysis</span>. <span class="source" tagx="source" title="source">PLoS ONE</span>. <span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">11</span>:<span class="elocation-id" tagx="elocation-id" title="elocation-id">e0166455</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27846307">27846307</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0068" /><span class="label" tagx="label" title="label">68</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Van Assche</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Manguso</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zibellini</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a doubleâ€�blind, randomized, parallel group study</span>. <span class="source" tagx="source" title="source">Am J Gastroenterol</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">110</span>:<span class="fpage" tagx="fpage" title="fpage">708</span>â€"<span class="lpage" tagx="lpage" title="lpage">715</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25869389">25869389</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0069" /><span class="label" tagx="label" title="label">69</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bonovas</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nikolopoulos</span><span class="given-names" tagx="given-names" title="given-names">GK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lytras</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Comparative safety of systemic and lowâ€�bioavailability steroids in inflammatory bowel disease: Systematic review and network metaâ€�analysis</span>. <span class="source" tagx="source" title="source">Br J Clin Pharmacol</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">84</span>:<span class="fpage" tagx="fpage" title="fpage">239</span>â€"<span class="lpage" tagx="lpage" title="lpage">251</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29057539">29057539</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0070" /><span class="label" tagx="label" title="label">70</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kirchgesner</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lemaitre</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Carrat</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases</span>. <span class="source" tagx="source" title="source">Gastroenterology</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">155</span>:<span class="fpage" tagx="fpage" title="fpage">337</span>â€"<span class="lpage" tagx="lpage" title="lpage">46</span>. e10.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29655835">29655835</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0071" /><span class="label" tagx="label" title="label">71</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Seksik</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cosnes</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sokol</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">29</span>:<span class="fpage" tagx="fpage" title="fpage">1106</span>â€"<span class="lpage" tagx="lpage" title="lpage">1113</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19222411">19222411</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0072" /><span class="label" tagx="label" title="label">72</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Kâ€�W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Sâ€�C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Wâ€�Y</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Thiopurine analogs and mycophenolic acid synergistically inhibit the papainâ€�like protease of Middle East respiratory syndrome coronavirus</span>. <span class="source" tagx="source" title="source">Antiviral Res</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">115</span>:<span class="fpage" tagx="fpage" title="fpage">9</span>â€"<span class="lpage" tagx="lpage" title="lpage">16</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25542975">25542975</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0073" /><span class="label" tagx="label" title="label">73</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ibrahim</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ahmed</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Conway</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Carey</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>. <span class="mixed-article-title" title="mixed-article-title">Risk of infection with methotrexate therapy in inflammatory diseases: a systematic review and metaâ€�analysis</span>. <span class="source" tagx="source" title="source">J Clin Med</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">15</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0074" /><span class="label" tagx="label" title="label">74</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Conway</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Low</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Coughlan</span><span class="given-names" tagx="given-names" title="given-names">RJ</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and metaâ€�analysis of randomised controlled trials</span>. <span class="source" tagx="source" title="source">BMJ</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">350</span>:<span class="fpage" tagx="fpage" title="fpage">h1269</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25770113">25770113</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0075" /><span class="label" tagx="label" title="label">75</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lichtenstein</span><span class="given-names" tagx="given-names" title="given-names">GR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Feagan</span><span class="given-names" tagx="given-names" title="given-names">BG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cohen</span><span class="given-names" tagx="given-names" title="given-names">RD</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Serious infection and mortality in patients with Crohn's disease: more than 5 years of followâ€�up in the TREAT registry</span>. <span class="source" tagx="source" title="source">Am J Gastroenterol</span>. <span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">107</span>:<span class="fpage" tagx="fpage" title="fpage">1409</span>â€"<span class="lpage" tagx="lpage" title="lpage">1422</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22890223">22890223</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0076" /><span class="label" tagx="label" title="label">76</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shah</span><span class="given-names" tagx="given-names" title="given-names">ED</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Farida</span><span class="given-names" tagx="given-names" title="given-names">JP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Siegel</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Risk for overall infection with antiâ€�TNF and antiâ€�integrin agents used in IBD: a systematic review and metaâ€�analysis</span>. <span class="source" tagx="source" title="source">Inflamm Bowel Dis</span>. <span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">570</span>â€"<span class="lpage" tagx="lpage" title="lpage">577</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28230558">28230558</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0077" /><span class="label" tagx="label" title="label">77</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Singh</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Facciorusso</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dulai</span><span class="given-names" tagx="given-names" title="given-names">PS</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Comparative risk of serious infections with biologic and/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and metaâ€�analysis</span>. <span class="source" tagx="source" title="source">Clin Gastroenterol Hepatol</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">18</span>:<span class="fpage" tagx="fpage" title="fpage">69</span>â€"<span class="lpage" tagx="lpage" title="lpage">81</span>. e3<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30876964">30876964</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0078" /><span class="label" tagx="label" title="label">78</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lv</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yi</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Antiâ€�TNFâ€�alpha therapy for patients with sepsis: a systematic metaâ€�analysis</span>. <span class="source" tagx="source" title="source">Int J Clin Pract</span>. <span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">68</span>:<span class="fpage" tagx="fpage" title="fpage">520</span>â€"<span class="lpage" tagx="lpage" title="lpage">528</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24548627">24548627</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0079" /><span class="label" tagx="label" title="label">79</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">VC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lau</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Woo</span><span class="given-names" tagx="given-names" title="given-names">PC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yuen</span><span class="given-names" tagx="given-names" title="given-names">KY</span></span>. <span class="mixed-article-title" title="mixed-article-title">Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection</span>. <span class="source" tagx="source" title="source">Clin Microbiol Rev</span>. <span class="year" tagx="year" title="year">2007</span>;<span class="volume" tagx="volume" title="volume">20</span>:<span class="fpage" tagx="fpage" title="fpage">660</span>â€"<span class="lpage" tagx="lpage" title="lpage">694</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17934078">17934078</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0080" /><span class="label" tagx="label" title="label">80</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Feagan</span><span class="given-names" tagx="given-names" title="given-names">BG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sandborn</span><span class="given-names" tagx="given-names" title="given-names">WJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gasink</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Ustekinumab as induction and maintenance therapy for Crohn's disease</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">375</span>:<span class="fpage" tagx="fpage" title="fpage">1946</span>â€"<span class="lpage" tagx="lpage" title="lpage">1960</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27959607">27959607</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0081" /><span class="label" tagx="label" title="label">81</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kalb</span><span class="given-names" tagx="given-names" title="given-names">RE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fiorentino</span><span class="given-names" tagx="given-names" title="given-names">DF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lebwohl</span><span class="given-names" tagx="given-names" title="given-names">MG</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Risk of serious infection with biologic and systemic treatment of psoriasis: results from the psoriasis longitudinal assessment and registry (PSOLAR)</span>. <span class="source" tagx="source" title="source">JAMA Dermatol</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">151</span>:<span class="fpage" tagx="fpage" title="fpage">961</span>â€"<span class="lpage" tagx="lpage" title="lpage">969</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25970800">25970800</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0082" /><span class="label" tagx="label" title="label">82</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hanauer</span><span class="given-names" tagx="given-names" title="given-names">SB</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sandborn</span><span class="given-names" tagx="given-names" title="given-names">WJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Feagan</span><span class="given-names" tagx="given-names" title="given-names">BG</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">IMâ€�UNITI: threeâ€�year efficacy, safety, and immunogenicity of ustekinumab treatment of Crohn's disease</span>. <span class="source" tagx="source" title="source">J Crohns Colitis</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">23</span>â€"<span class="lpage" tagx="lpage" title="lpage">32</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31158271">31158271</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0083" /><span class="label" tagx="label" title="label">83</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bye</span><span class="given-names" tagx="given-names" title="given-names">WA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jairath</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Travis</span><span class="given-names" tagx="given-names" title="given-names">SPL</span></span>. <span class="mixed-article-title" title="mixed-article-title">Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">46</span>:<span class="fpage" tagx="fpage" title="fpage">3</span>â€"<span class="lpage" tagx="lpage" title="lpage">15</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28449273">28449273</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0084" /><span class="label" tagx="label" title="label">84</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mocko</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kawalec</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pilc</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>. <span class="mixed-article-title" title="mixed-article-title">Safety profile of biologic drugs in the therapy of Crohn disease: a systematic review and network metaâ€�analysis</span>. <span class="source" tagx="source" title="source">Pharmacol Rep</span>. <span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">68</span>:<span class="fpage" tagx="fpage" title="fpage">1237</span>â€"<span class="lpage" tagx="lpage" title="lpage">1243</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27686963">27686963</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0085" /><span class="label" tagx="label" title="label">85</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mocko</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kawalec</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pilc</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>. <span class="mixed-article-title" title="mixed-article-title">Safety profile of biologic drugs in the therapy of ulcerative colitis: a systematic review and network metaâ€�analysis</span>. <span class="source" tagx="source" title="source">Pharmacotherapy</span>. <span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">36</span>:<span class="fpage" tagx="fpage" title="fpage">870</span>â€"<span class="lpage" tagx="lpage" title="lpage">879</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27312826">27312826</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0086" /><span class="label" tagx="label" title="label">86</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Colombel</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sands</span><span class="given-names" tagx="given-names" title="given-names">BE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rutgeerts</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">The safety of vedolizumab for ulcerative colitis and Crohn's disease</span>. <span class="source" tagx="source" title="source">Gut</span>. <span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">66</span>:<span class="fpage" tagx="fpage" title="fpage">839</span>â€"<span class="lpage" tagx="lpage" title="lpage">851</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26893500">26893500</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0087" /><span class="label" tagx="label" title="label">87</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bourges</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chevaleyre</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Differential expression of adhesion molecules and chemokines between nasal and small intestinal mucosae: implications for Tâ€� and sIgA+ Bâ€�lymphocyte recruitment</span>. <span class="source" tagx="source" title="source">Immunology</span>. <span class="year" tagx="year" title="year">2007</span>;<span class="volume" tagx="volume" title="volume">122</span>:<span class="fpage" tagx="fpage" title="fpage">551</span>â€"<span class="lpage" tagx="lpage" title="lpage">561</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17635614">17635614</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0088" /><span class="label" tagx="label" title="label">88</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Van Assche</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vermeire</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ballet</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial</span>. <span class="source" tagx="source" title="source">Gut</span>. <span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">61</span>:<span class="fpage" tagx="fpage" title="fpage">229</span>â€"<span class="lpage" tagx="lpage" title="lpage">234</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21948942">21948942</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0089" /><span class="label" tagx="label" title="label">89</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Winthrop</span><span class="given-names" tagx="given-names" title="given-names">KL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Melmed</span><span class="given-names" tagx="given-names" title="given-names">GY</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vermeire</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib</span>. <span class="source" tagx="source" title="source">Inflamm Bowel Dis</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">2258</span>â€"<span class="lpage" tagx="lpage" title="lpage">2265</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29850873">29850873</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0090" /><span class="label" tagx="label" title="label">90</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wollenhaupt</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">EB</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Curtis</span><span class="given-names" tagx="given-names" title="given-names">JR</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, openâ€�label, longâ€�term extension study</span>. <span class="source" tagx="source" title="source">Arthritis Res Ther</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">89</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30953540">30953540</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0091" /><span class="label" tagx="label" title="label">91</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sandborn</span><span class="given-names" tagx="given-names" title="given-names">WJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Su</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sands</span><span class="given-names" tagx="given-names" title="given-names">BE</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Tofacitinib as induction and maintenance therapy for ulcerative colitis</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">376</span>:<span class="fpage" tagx="fpage" title="fpage">1723</span>â€"<span class="lpage" tagx="lpage" title="lpage">1736</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28467869">28467869</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0092" /><span class="label" tagx="label" title="label">92</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Harigai</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>. <span class="mixed-article-title" title="mixed-article-title">Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis</span>. <span class="source" tagx="source" title="source">Rheumatology (Oxford)</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">58</span>(<span class="issue" tagx="issue" title="issue">Suppl 1</span>):<span class="fpage" tagx="fpage" title="fpage">i34</span>â€"<span class="lpage" tagx="lpage" title="lpage">i42</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30806708">30806708</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0093" /><span class="label" tagx="label" title="label">93</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Weisshof</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Aharoni Golan</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sossenheimer</span><span class="given-names" tagx="given-names" title="given-names">PH</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Realâ€�world experience with tofacitinib in IBD at a Tertiary Center</span>. <span class="source" tagx="source" title="source">Dig Dis Sci</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">64</span>:<span class="fpage" tagx="fpage" title="fpage">1945</span>â€"<span class="lpage" tagx="lpage" title="lpage">1951</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30734234">30734234</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0094" /><span class="label" tagx="label" title="label">94</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Stebbing</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Phelan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Griffin</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">COVIDâ€�19: combining antiviral and antiâ€�inflammatory treatments</span>. <span class="source" tagx="source" title="source">Lancet Infect Dis</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">20</span>:<span class="fpage" tagx="fpage" title="fpage">400</span>â€"<span class="lpage" tagx="lpage" title="lpage">402</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32113509">32113509</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0095" /><span class="label" tagx="label" title="label">95</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: European Centre for Disease Prevention and Control</span> . <span class="mixed-article-title" title="mixed-article-title">Technical Report: Guidance for discharge and ending isolation in the context of widespread community transmission of COVIDâ€�19 â€" first update</span>. <a href="https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidance-discharge-and-ending-isolation-first%2520update.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidance-discharge-and-ending-isolation-first%2520update.pdf</a>. Accessed April 11, 2020.</span></li> <li tag="ref"><a name="apt15779-bib-0096" /><span class="label" tagx="label" title="label">96</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ananthakrishnan</span><span class="given-names" tagx="given-names" title="given-names">AN</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McGinley</span><span class="given-names" tagx="given-names" title="given-names">EL</span></span>. <span class="mixed-article-title" title="mixed-article-title">Infectionâ€�related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases</span>. <span class="source" tagx="source" title="source">J Crohns Colitis</span>. <span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">107</span>â€"<span class="lpage" tagx="lpage" title="lpage">112</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22440891">22440891</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0097" /><span class="label" tagx="label" title="label">97</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fong</span><span class="given-names" tagx="given-names" title="given-names">MW</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">JY</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Nonpharmaceutical measures for pandemic influenza in nonhealthcare settingsâ€�social distancing measures</span>. <span class="source" tagx="source" title="source">Emerg Infect Dis</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">26</span>:<span class="fpage" tagx="fpage" title="fpage">976</span>â€"<span class="lpage" tagx="lpage" title="lpage">984</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32027585">32027585</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0098" /><span class="label" tagx="label" title="label">98</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ahmed</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zviedrite</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Uzicanin</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>. <span class="mixed-article-title" title="mixed-article-title">Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review</span>. <span class="source" tagx="source" title="source">BMC Public Health</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">18</span>:<span class="fpage" tagx="fpage" title="fpage">518</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29669545">29669545</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0099" /><span class="label" tagx="label" title="label">99</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hollander</span><span class="given-names" tagx="given-names" title="given-names">JE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Carr</span><span class="given-names" tagx="given-names" title="given-names">BG</span></span>. <span class="mixed-article-title" title="mixed-article-title">Virtually perfect? Telemedicine for Covidâ€�19</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">382</span>:<span class="fpage" tagx="fpage" title="fpage">1679</span>â€"<span class="lpage" tagx="lpage" title="lpage">1681</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32160451">32160451</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0100" /><span class="label" tagx="label" title="label">100</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Clare</span><span class="given-names" tagx="given-names" title="given-names">DF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Alexander</span><span class="given-names" tagx="given-names" title="given-names">FC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mike</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Eur J Gastroenterol Hepatol</span>. <span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">71</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19060632">19060632</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0101" /><span class="label" tagx="label" title="label">101</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: World Health Organisation</span> .<span class="mixed-article-title" title="mixed-article-title">A multiâ€�centre, adaptive, randomized, doubleâ€�blind, placebocontrolled clinical trial of the safety and efficacy of investigational therapeutics for the treatment of COVIDâ€�19 in hospitalized patients</span>.<span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0102" /><span class="label" tagx="label" title="label">102</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Agostini</span><span class="given-names" tagx="given-names" title="given-names">ML</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Andres</span><span class="given-names" tagx="given-names" title="given-names">EL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sims</span><span class="given-names" tagx="given-names" title="given-names">AC</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Coronavirus susceptibility to the antiviral remdesivir (GSâ€�5734) is mediated by the viral polymerase and the proofreading exoribonuclease</span>. <span class="source" tagx="source" title="source">mBio</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">9</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0103" /><span class="label" tagx="label" title="label">103</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019â€�nCoV) in vitro</span>. <span class="source" tagx="source" title="source">Cell Res</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">30</span>:<span class="fpage" tagx="fpage" title="fpage">269</span>â€"<span class="lpage" tagx="lpage" title="lpage">271</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32020029">32020029</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0104" /><span class="label" tagx="label" title="label">104</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>. <span class="mixed-article-title" title="mixed-article-title">Drug treatment options for the 2019â€�new coronavirus (2019â€�nCoV)</span>. <span class="source" tagx="source" title="source">BioSci Trends</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0105" /><span class="label" tagx="label" title="label">105</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chu</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">VC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hung</span><span class="given-names" tagx="given-names" title="given-names">IF</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings</span>. <span class="source" tagx="source" title="source">Thorax</span>. <span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">59</span>:<span class="fpage" tagx="fpage" title="fpage">252</span>â€"<span class="lpage" tagx="lpage" title="lpage">256</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14985565">14985565</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0106" /><span class="label" tagx="label" title="label">106</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">JF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yao</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yeung</span><span class="given-names" tagx="given-names" title="given-names">ML</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Treatment with lopinavir/ritonavir or interferonâ€�beta1b improves outcome of MERSâ€�CoV infection in a nonhuman primate model of common marmoset</span>. <span class="source" tagx="source" title="source">J Infect Dis</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">212</span>:<span class="fpage" tagx="fpage" title="fpage">1904</span>â€"<span class="lpage" tagx="lpage" title="lpage">1913</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26198719">26198719</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0107" /><span class="label" tagx="label" title="label">107</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wen</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">A trial of lopinavirâ€�ritonavir in adults hospitalized with severe Covidâ€�19</span>. <span class="source" tagx="source" title="source">N Engl J Med</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0108" /><span class="label" tagx="label" title="label">108</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Devaux</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rolain</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Colson</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Raoult</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>. <span class="mixed-article-title" title="mixed-article-title">New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVIDâ€�19?</span><span class="source" tagx="source" title="source">Int J Antimicrob Agents</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0109" /><span class="label" tagx="label" title="label">109</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Colson</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rolain</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lagier</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Chloroquine and hydroxychloroquine as available weapons to fight COVIDâ€�19</span>. <span class="source" tagx="source" title="source">Int J Antimicrob Agents</span>. <span class="year" tagx="year" title="year">2020</span>;105932.</span></li> <li tag="ref"><a name="apt15779-bib-0110" /><span class="label" tagx="label" title="label">110</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Colson</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rolain</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Raoult</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>. <span class="mixed-article-title" title="mixed-article-title">Chloroquine for the 2019 novel coronavirus SARSâ€�CoVâ€�2</span>. <span class="source" tagx="source" title="source">Int J Antimicrob Agents</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">55</span>:<span class="fpage" tagx="fpage" title="fpage">105923</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32070753">32070753</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0111" /><span class="label" tagx="label" title="label">111</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gautret</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lagier</span><span class="given-names" tagx="given-names" title="given-names">Jâ€�C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Parola</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Hydroxychloroquine and azithromycin as a treatment of COVIDâ€�19: results of an openâ€�label nonâ€�randomized clinical trial</span>. <span class="source" tagx="source" title="source">Int J Antimicrob Agents</span>. <span class="year" tagx="year" title="year">2020</span>;105949.</span></li> <li tag="ref"><a name="apt15779-bib-0112" /><span class="label" tagx="label" title="label">112</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">De Clercq</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>. <span class="mixed-article-title" title="mixed-article-title">Therapeutic options for the 2019 novel coronavirus (2019â€�nCoV)</span>. <span class="source" tagx="source" title="source">Nat Rev Drug Discov</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">149</span>â€"<span class="lpage" tagx="lpage" title="lpage">150</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32127666">32127666</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0113" /><span class="label" tagx="label" title="label">113</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Faviiravir versus arbidol for COVIDâ€� 19: a randomized clinical trial</span>. [In press]. <span class="source" tagx="source" title="source">medRxiv</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0114" /><span class="label" tagx="label" title="label">114</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="mixed-article-title" title="mixed-article-title">Chinese Clinical Trials Registry 2020</span>. <a href="http://www.chictr.org.cn/searchprojen.aspx?title=COVID-19%26officialname=%26subjectid=%26secondaryid=%26applier=%26studyleader=%26ethicalcommitteesanction=%26sponsor=%26studyailment=%26studyailmentcode=%26studytype=0%26studystage=0%26studydesign=0%26minstudyexecutetime=%26maxstudyexecutetime=%26recruitmentstatus=0%26gender=0%26agreetosign=%26secsponsor=%26regno=%26regstatus=0%26country=%26province=%26city=%26institution=%26institutionlevel=%26measure=%26intercode=%26sourceofspends=%26createyear=0%26isuploadrf=%26whetherpublic=%26btngo=btn%26verifycode=%26page=1">http://www.chictr.org.cn/searchprojen.aspx?title=COVID-19%26officialname=%26subjectid=%26secondaryid=%26applier=%26studyleader=%26ethicalcommitteesanction=%26sponsor=%26studyailment=%26studyailmentcode=%26studytype=0%26studystage=0%26studydesign=0%26minstudyexecutetime=%26maxstudyexecutetime=%26recruitmentstatus=0%26gender=0%26agreetosign=%26secsponsor=%26regno=%26regstatus=0%26country=%26province=%26city=%26institution=%26institutionlevel=%26measure=%26intercode=%26sourceofspends=%26createyear=0%26isuploadrf=%26whetherpublic=%26btngo=btn%26verifycode=%26page=1</a></span></li> <li tag="ref"><a name="apt15779-bib-0115" /><span class="label" tagx="label" title="label">115</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schwartz</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">King</span><span class="given-names" tagx="given-names" title="given-names">Câ€�C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yen</span><span class="given-names" tagx="given-names" title="given-names">Mâ€�Y</span></span>.Protecting healthcare workers during the coronavirus disease 2019 (COVIDâ€�19) outbreak: lessons from Taiwanâ€™s severe acute respiratory syndrome response.<span class="mixed-article-title" title="mixed-article-title">Clin Infect Dis</span>. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0116" /><span class="label" tagx="label" title="label">116</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Clinical course and risk factors for mortality of adult inpatients with COVIDâ€�19 in Wuhan, China: a retrospective cohort study</span>. <span class="source" tagx="source" title="source">Lancet</span>. <span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">395</span>:<span class="fpage" tagx="fpage" title="fpage">1054</span>â€"<span class="lpage" tagx="lpage" title="lpage">1062</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171076">32171076</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0117" /><span class="label" tagx="label" title="label">117</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Phan</span><span class="given-names" tagx="given-names" title="given-names">LT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Maita</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mortiz</span><span class="given-names" tagx="given-names" title="given-names">DC</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Contact and selfâ€�contact patterns of healthcare workers: implications for infection prevention and control</span>. <span class="source" tagx="source" title="source">Clin Infect Dis</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">69</span>(<span class="issue" tagx="issue" title="issue">Supplement_3</span>):<span class="fpage" tagx="fpage" title="fpage">S178</span>â€"<span class="lpage" tagx="lpage" title="lpage">S184</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31517975">31517975</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0118" /><span class="label" tagx="label" title="label">118</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kuenzig</span><span class="given-names" tagx="given-names" title="given-names">ME</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rezaie</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kaplan</span><span class="given-names" tagx="given-names" title="given-names">GG</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Budesonide for the induction and maintenance of remission in Crohn's disease: systematic review and metaâ€�analysis for the Cochrane collaboration</span>. <span class="source" tagx="source" title="source">J Can Assoc Gastroenterol</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">1</span>:<span class="fpage" tagx="fpage" title="fpage">159</span>â€"<span class="lpage" tagx="lpage" title="lpage">173</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30656288">30656288</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0119" /><span class="label" tagx="label" title="label">119</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rizzello</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gionchetti</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">D'Arienzo</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a doubleâ€�blind placeboâ€�controlled study</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2002</span>;<span class="volume" tagx="volume" title="volume">16</span>(<span class="issue" tagx="issue" title="issue">6</span>):<span class="fpage" tagx="fpage" title="fpage">1109</span>â€"<span class="lpage" tagx="lpage" title="lpage">1116</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12030952">12030952</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0120" /><span class="label" tagx="label" title="label">120</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Feagan</span><span class="given-names" tagx="given-names" title="given-names">BG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bhayat</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Khalid</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Respiratory tract infections in patients with inflammatory bowel disease: safety analyses from vedolizumab clinical trials</span>. <span class="source" tagx="source" title="source">J Crohns Colitis</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">905</span>â€"<span class="lpage" tagx="lpage" title="lpage">919</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29788248">29788248</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0121" /><span class="label" tagx="label" title="label">121</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="mixed-article-title" title="mixed-article-title">Tofacitinib [Internet].Truven Health Analytics</span>. <span class="year" tagx="year" title="year">2020</span> [cited 14 March 2020]. <a href="http://www.micromedexsolutions.com">http://www.micromedexsolutions.com</a>. Subscription required to view.</span></li> <li tag="ref"><a name="apt15779-bib-0122" /><span class="label" tagx="label" title="label">122</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="mixed-article-title" title="mixed-article-title">Tofacitinib [Internet].Truven Health Analytics</span>. <span class="year" tagx="year" title="year">2020</span> [cited 14 March 2020]. <a href="http://www.micromedexsolutions.com">http://www.micromedexsolutions.com</a>. Subscription required to view.</span></li> <li tag="ref"><a name="apt15779-bib-0123" /><span class="label" tagx="label" title="label">123</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cohen</span><span class="given-names" tagx="given-names" title="given-names">SB</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tanaka</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mariette</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Longâ€�term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials</span>. <span class="source" tagx="source" title="source">Ann Rheum Dis</span>. <span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">76</span>:<span class="fpage" tagx="fpage" title="fpage">1253</span>â€"<span class="lpage" tagx="lpage" title="lpage">1262</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28143815">28143815</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0124" /><span class="label" tagx="label" title="label">124</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Derijks</span><span class="given-names" tagx="given-names" title="given-names">LJJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">DR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hommes</span><span class="given-names" tagx="given-names" title="given-names">DW</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">van Bodegraven</span><span class="given-names" tagx="given-names" title="given-names">AA</span></span>. <span class="mixed-article-title" title="mixed-article-title">Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Clin Pharmacokinet</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">57</span>:<span class="fpage" tagx="fpage" title="fpage">1075</span>â€"<span class="lpage" tagx="lpage" title="lpage">1106</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29512050">29512050</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0125" /><span class="label" tagx="label" title="label">125</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gisbert</span><span class="given-names" tagx="given-names" title="given-names">JP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nino</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cara</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rodrigo</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>. <span class="mixed-article-title" title="mixed-article-title">Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, longâ€�term, followâ€�up study of 394 patients</span>. <span class="source" tagx="source" title="source">Aliment Pharmacol Ther</span>. <span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">228</span>â€"<span class="lpage" tagx="lpage" title="lpage">238</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18485129">18485129</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0126" /><span class="label" tagx="label" title="label">126</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Benâ€�Horin</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Van Assche</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chowers</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Pharmacokinetics and immune reconstitution following discontinuation of thiopurine analogues: implications for drug withdrawal strategies</span>. <span class="source" tagx="source" title="source">J Crohns Colitis</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">1410</span>â€"<span class="lpage" tagx="lpage" title="lpage">1417</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30169593">30169593</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0127" /><span class="label" tagx="label" title="label">127</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vande Casteele</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Baert</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bian</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">subcutaneous absorption contributes to observed interindividual variability in adalimumab serum concentrations in Crohn's disease: a prospective multicentre study</span>. <span class="source" tagx="source" title="source">J Crohns Colitis</span>. <span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">1248</span>â€"<span class="lpage" tagx="lpage" title="lpage">1256</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30820530">30820530</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0128" /><span class="label" tagx="label" title="label">128</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ternant</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bejanâ€�Angoulvant</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Passot</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Clinical pharmacokinetics and pharmacodynamics of monoclonal antibodies approved to treat rheumatoid arthritis</span>. <span class="source" tagx="source" title="source">Clin Pharmacokinet</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">54</span>:<span class="fpage" tagx="fpage" title="fpage">1107</span>â€"<span class="lpage" tagx="lpage" title="lpage">1123</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26123705">26123705</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0129" /><span class="label" tagx="label" title="label">129</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Klotz</span><span class="given-names" tagx="given-names" title="given-names">U</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Teml</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schwab</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>. <span class="mixed-article-title" title="mixed-article-title">Clinical pharmacokinetics and use of infliximab</span>. <span class="source" tagx="source" title="source">Clin Pharmacokinet</span>. <span class="year" tagx="year" title="year">2007</span>;<span class="volume" tagx="volume" title="volume">48</span>:<span class="fpage" tagx="fpage" title="fpage">645</span>â€"<span class="lpage" tagx="lpage" title="lpage">660</span>.</span></li> <li tag="ref"><a name="apt15779-bib-0130" /><span class="label" tagx="label" title="label">130</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ternant</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Aubourg</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Magdelaineâ€�Beuzelin</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Infliximab pharmacokinetics in inflammatory bowel disease patients</span>. <span class="source" tagx="source" title="source">Ther Drug Monit</span>. <span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">30</span>:<span class="fpage" tagx="fpage" title="fpage">523</span>â€"<span class="lpage" tagx="lpage" title="lpage">529</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18641542">18641542</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0131" /><span class="label" tagx="label" title="label">131</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hemperly</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vande</span><span class="given-names" tagx="given-names" title="given-names">CN</span></span>. <span class="mixed-article-title" title="mixed-article-title">Clinical pharmacokinetics and pharmacodynamics of infliximab in the treatment of inflammatory bowel disease</span>. <span class="source" tagx="source" title="source">Clin Pharmacokinet</span>. <span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">57</span>:<span class="fpage" tagx="fpage" title="fpage">929</span>â€"<span class="lpage" tagx="lpage" title="lpage">942</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29330783">29330783</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0132" /><span class="label" tagx="label" title="label">132</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cronstein</span><span class="given-names" tagx="given-names" title="given-names">BN</span></span>. <span class="mixed-article-title" title="mixed-article-title">Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</span>. <span class="source" tagx="source" title="source">Bull NYU Hosp Jt Dis</span>. <span class="year" tagx="year" title="year">2007</span>;<span class="volume" tagx="volume" title="volume">65</span>:<span class="fpage" tagx="fpage" title="fpage">168</span>â€"<span class="lpage" tagx="lpage" title="lpage">173</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17922664">17922664</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0133" /><span class="label" tagx="label" title="label">133</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Best</span><span class="given-names" tagx="given-names" title="given-names">BM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Capparelli</span><span class="given-names" tagx="given-names" title="given-names">EV</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Diep</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children</span>. <span class="source" tagx="source" title="source">J Acquir Immune Defic Syndr</span>. <span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">58</span>:<span class="fpage" tagx="fpage" title="fpage">385</span>â€"<span class="lpage" tagx="lpage" title="lpage">391</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21876444">21876444</a></span></span></li> <li tag="ref"><a name="apt15779-bib-0134" /><span class="label" tagx="label" title="label">134</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Quetglas</span><span class="given-names" tagx="given-names" title="given-names">EG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Armuzzi</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wigge</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, et al. <span class="mixed-article-title" title="mixed-article-title">Review article: the pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment</span>. <span class="source" tagx="source" title="source">Eur J Clin Pharmacol</span>. <span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">71</span>:<span class="fpage" tagx="fpage" title="fpage">773</span>â€"<span class="lpage" tagx="lpage" title="lpage">799</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26008212">26008212</a></span></span></li> </ul> </div> </div>  </body></html>